High-intermediate risk groups in FIGO stage I endometrial cancer as defined by PORTEC-1 and GOG 99.
\\n\\n
Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\\n\\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
\\n"}]',published:!0,mainMedia:null},components:[{type:"htmlEditorComponent",content:'IntechOpen is proud to announce that 179 of our authors have made the Clarivate™ Highly Cited Researchers List for 2020, ranking them among the top 1% most-cited.
\n\nThroughout the years, the list has named a total of 252 IntechOpen authors as Highly Cited. Of those researchers, 69 have been featured on the list multiple times.
\n\n\n\nReleased this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\n\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
\n'}],latestNews:[{slug:"stanford-university-identifies-top-2-scientists-over-1-000-are-intechopen-authors-and-editors-20210122",title:"Stanford University Identifies Top 2% Scientists, Over 1,000 are IntechOpen Authors and Editors"},{slug:"intechopen-authors-included-in-the-highly-cited-researchers-list-for-2020-20210121",title:"IntechOpen Authors Included in the Highly Cited Researchers List for 2020"},{slug:"intechopen-maintains-position-as-the-world-s-largest-oa-book-publisher-20201218",title:"IntechOpen Maintains Position as the World’s Largest OA Book Publisher"},{slug:"all-intechopen-books-available-on-perlego-20201215",title:"All IntechOpen Books Available on Perlego"},{slug:"oiv-awards-recognizes-intechopen-s-editors-20201127",title:"OIV Awards Recognizes IntechOpen's Editors"},{slug:"intechopen-joins-crossref-s-initiative-for-open-abstracts-i4oa-to-boost-the-discovery-of-research-20201005",title:"IntechOpen joins Crossref's Initiative for Open Abstracts (I4OA) to Boost the Discovery of Research"},{slug:"intechopen-hits-milestone-5-000-open-access-books-published-20200908",title:"IntechOpen hits milestone: 5,000 Open Access books published!"},{slug:"intechopen-books-hosted-on-the-mathworks-book-program-20200819",title:"IntechOpen Books Hosted on the MathWorks Book Program"}]},book:{item:{type:"book",id:"5728",leadTitle:null,fullTitle:"Colposcopy and Cervical Pathology",title:"Colposcopy and Cervical Pathology",subtitle:null,reviewType:"peer-reviewed",abstract:'This book entitled Colposcopy and Cervical Pathology is the third successful book of the editor with InTech publishers. This book serves the purpose of providing, valuable and valid, innovative ideas/suggestions for utilizations of the "resource-rich/resource-intensive" colposcopy and cervical pathology technology in a "cost-/resource-effective" way by the health providers and planners, especially in "resource-limited/resource-poor settings." Transfer of technology from high- to low-resource settings in all the programs of preventive/community oncology services, across the world, is highly recommended and strongly advocated. The authors have well contributed to the goal of advanced science being made accessible for the benefit of common man. The InTech publishers have the distinct honor of imbibing the in-depth knowledge and vast experiences from experts of international repute and infusing it to the health providers and planners of developing countries, so that the communities of all nations are richly benefited. The book is a pearl, which deserves a precious and purposeful planning model for achieving "global health by education and empowerment."',isbn:"978-953-51-3538-8",printIsbn:"978-953-51-3537-1",pdfIsbn:"978-953-51-4646-9",doi:"10.5772/65158",price:119,priceEur:129,priceUsd:155,slug:"colposcopy-and-cervical-pathology",numberOfPages:148,isOpenForSubmission:!1,isInWos:1,hash:"f4232ee2dc701c710f42172d09afdc8f",bookSignature:"Rajamanickam Rajkumar",publishedDate:"September 20th 2017",coverURL:"https://cdn.intechopen.com/books/images_new/5728.jpg",numberOfDownloads:5912,numberOfWosCitations:2,numberOfCrossrefCitations:2,numberOfDimensionsCitations:4,hasAltmetrics:0,numberOfTotalCitations:8,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"September 7th 2016",dateEndSecondStepPublish:"November 10th 2016",dateEndThirdStepPublish:"February 2nd 2017",dateEndFourthStepPublish:"March 30th 2017",dateEndFifthStepPublish:"June 1st 2017",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,editors:[{id:"120109",title:"Dr.",name:"Rajamanickam",middleName:null,surname:"Rajkumar",slug:"rajamanickam-rajkumar",fullName:"Rajamanickam Rajkumar",profilePictureURL:"https://mts.intechopen.com/storage/users/120109/images/system/120109.jfif",biography:"Rajamanickam Rajkumar is a scientist on the front lines of cervical cancer and HPV prevention and control. He has an MD\nin Community Medicine and a Ph.D. in Cancer Epidemiology. He is currently a professor at Meenakshi Medical College Kanchipuram, India, and a Ph.D. mentor at many medical universities. He was the principal investigator for one of the largest Cervical cancer screening programs in India with technical support from the International Agency for Research on Cancer (IARC), a specialized agency of the World Health Organization. He conducted the first study in South India on the\ncommunity prevalence of HPV. He has been trained in colposcopy and cancer epidemiology in France, Ireland, the United Kingdom, and Singapore. He is a consultant to the Ohio State University Medical University in Cervical Cancer Screening\nand an Honorary Member of the Society for Colposcopy & Cervical Pathology of Singapore (SCCPS). Since the start of 2020, he has served as Associate Research Director and Member Secretary of the Institutional Ethics Committee of Meenakshi\nMedical College. Dr. Rajkumar has won several awards, including Best Teacher and Researcher from the Meenakshi Academy of Higher Education and Research, India, in 2013, and Excellence in Research from the Institute of Scholars, India, in 2019. He is a Certified Publons Academy Peer Reviewer from June 2020.",institutionString:"Meenakshi Medical College Hospital and Research Institute",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"5",totalChapterViews:"0",totalEditedBooks:"5",institution:{name:"Meenakshi Medical College Hospital and Research Institute",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1071",title:"Urogynecology",slug:"urogynecology"}],chapters:[{id:"56122",title:"Introductory Chapter: Colposcopy and Cervical Pathology in Cervical Cancer Screening Programs: Resource Effectiveness, Concepts, and Models of “Raj”©",doi:"10.5772/intechopen.69692",slug:"introductory-chapter-colposcopy-and-cervical-pathology-in-cervical-cancer-screening-programs-resourc",totalDownloads:705,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Rajamanickam Rajkumar",downloadPdfUrl:"/chapter/pdf-download/56122",previewPdfUrl:"/chapter/pdf-preview/56122",authors:[{id:"120109",title:"Dr.",name:"Rajamanickam",surname:"Rajkumar",slug:"rajamanickam-rajkumar",fullName:"Rajamanickam Rajkumar"}],corrections:null},{id:"55613",title:"Psychosocial Aspects of Colposcopic Assessment: Perspectives and Strategies for Physicians",doi:"10.5772/intechopen.69160",slug:"psychosocial-aspects-of-colposcopic-assessment-perspectives-and-strategies-for-physicians",totalDownloads:717,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Eugen Ancuta, Dumitru Sofroni, Codrina Ancuta, Larisa Sofroni, Ion\nMereuta, Lilian Gutu and Emil Anton",downloadPdfUrl:"/chapter/pdf-download/55613",previewPdfUrl:"/chapter/pdf-preview/55613",authors:[{id:"35586",title:"Prof.",name:"Codrina",surname:"Ancuta",slug:"codrina-ancuta",fullName:"Codrina Ancuta"}],corrections:null},{id:"56814",title:"Colposcopy of the Vulva and Perineum",doi:"10.5772/intechopen.68768",slug:"colposcopy-of-the-vulva-and-perineum",totalDownloads:1421,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Marta García-Yuste González, Ana Maria Muñoz Ledesma, Mayte Navarro Monge and José Schneider Fontán",downloadPdfUrl:"/chapter/pdf-download/56814",previewPdfUrl:"/chapter/pdf-preview/56814",authors:[{id:"195677",title:"Prof.",name:"Marta",surname:"García -Yuste",slug:"marta-garcia-yuste",fullName:"Marta García -Yuste"},{id:"195987",title:"Prof.",name:"Ana",surname:"Muñoz Ledesma",slug:"ana-munoz-ledesma",fullName:"Ana Muñoz Ledesma"},{id:"195988",title:"Dr.",name:"Mayte",surname:"Navarro Monge",slug:"mayte-navarro-monge",fullName:"Mayte Navarro Monge"}],corrections:null},{id:"55592",title:"Colposcopic Assessment Among Women with Lower Genital Tract Pathology",doi:"10.5772/intechopen.69176",slug:"colposcopic-assessment-among-women-with-lower-genital-tract-pathology",totalDownloads:805,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Eugen Ancuta, Dumitru Sofroni, Codrina Ancuta, Larisa Sofroni, Ion\nMereuta and Lilian Gutu",downloadPdfUrl:"/chapter/pdf-download/55592",previewPdfUrl:"/chapter/pdf-preview/55592",authors:[{id:"35586",title:"Prof.",name:"Codrina",surname:"Ancuta",slug:"codrina-ancuta",fullName:"Codrina Ancuta"},{id:"53221",title:"MSc.",name:"Eugen",surname:"Ancuta",slug:"eugen-ancuta",fullName:"Eugen Ancuta"},{id:"196666",title:"MSc.",name:"Dumitru",surname:"Sofroni",slug:"dumitru-sofroni",fullName:"Dumitru Sofroni"}],corrections:null},{id:"55650",title:"Utility of Colposcopy: Comparison of Colposcopic Abnormality with Histology and Cytology, with Colposcopic Findings Focusing on the Lesion in Cervical Canal",doi:"10.5772/intechopen.68358",slug:"utility-of-colposcopy-comparison-of-colposcopic-abnormality-with-histology-and-cytology-with-colposc",totalDownloads:676,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Hiroyuki Kuramoto and Toshiko Jobo",downloadPdfUrl:"/chapter/pdf-download/55650",previewPdfUrl:"/chapter/pdf-preview/55650",authors:[{id:"196678",title:"Emeritus Prof.",name:"Hiroyuki",surname:"Kuramoto",slug:"hiroyuki-kuramoto",fullName:"Hiroyuki Kuramoto"},{id:"205916",title:"Prof.",name:"Toshiko",surname:"Jobo",slug:"toshiko-jobo",fullName:"Toshiko Jobo"}],corrections:null},{id:"54716",title:"MiRNAs in Cervical Cancer Radio- and Chemotherapy Response",doi:"10.5772/68010",slug:"mirnas-in-cervical-cancer-radio-and-chemotherapy-response",totalDownloads:652,totalCrossrefCites:2,totalDimensionsCites:3,signatures:"Jesús Adrián López and Angelica Judith Granados López",downloadPdfUrl:"/chapter/pdf-download/54716",previewPdfUrl:"/chapter/pdf-preview/54716",authors:[{id:"196431",title:"M.Sc.",name:"Angelica Judith",surname:"Granados López",slug:"angelica-judith-granados-lopez",fullName:"Angelica Judith Granados López"},{id:"196441",title:"Dr.",name:"Jesús Adrián",surname:"López",slug:"jesus-adrian-lopez",fullName:"Jesús Adrián López"}],corrections:null},{id:"54747",title:"The Role of miRNAs in Diagnosis, Prognosis and Treatment Prediction in Cervical Cancer",doi:"10.5772/68011",slug:"the-role-of-mirnas-in-diagnosis-prognosis-and-treatment-prediction-in-cervical-cancer",totalDownloads:945,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Ovidiu Balacescu, Loredana Balacescu, Oana Baldasici, Oana\nTudoran and Patriciu Achimas‐Cadariu",downloadPdfUrl:"/chapter/pdf-download/54747",previewPdfUrl:"/chapter/pdf-preview/54747",authors:[{id:"195763",title:"Ph.D.",name:"Ovidiu",surname:"Balacescu",slug:"ovidiu-balacescu",fullName:"Ovidiu Balacescu"},{id:"196758",title:"Dr.",name:"Loreadana",surname:"Balacescu",slug:"loreadana-balacescu",fullName:"Loreadana Balacescu"},{id:"196761",title:"Dr.",name:"Oana",surname:"Tudoran",slug:"oana-tudoran",fullName:"Oana Tudoran"},{id:"196770",title:"Prof.",name:"Patriciu",surname:"Achimas",slug:"patriciu-achimas",fullName:"Patriciu Achimas"},{id:"203875",title:"Dr.",name:"Oana",surname:"Baldasici",slug:"oana-baldasici",fullName:"Oana Baldasici"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},relatedBooks:[{type:"book",id:"951",title:"Topics on Cervical Cancer With an Advocacy for Prevention",subtitle:null,isOpenForSubmission:!1,hash:"fedfb0b32d856abf87bdb68b8ce9791c",slug:"topics-on-cervical-cancer-with-an-advocacy-for-prevention",bookSignature:"Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/951.jpg",editedByType:"Edited by",editors:[{id:"120109",title:"Dr.",name:"Rajamanickam",surname:"Rajkumar",slug:"rajamanickam-rajkumar",fullName:"Rajamanickam Rajkumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5256",title:"Human Papillomavirus",subtitle:"Research in a Global Perspective",isOpenForSubmission:!1,hash:"8d66d3c0bc41a12be8217ca0cee52b60",slug:"human-papillomavirus-research-in-a-global-perspective",bookSignature:"Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/5256.jpg",editedByType:"Edited by",editors:[{id:"120109",title:"Dr.",name:"Rajamanickam",surname:"Rajkumar",slug:"rajamanickam-rajkumar",fullName:"Rajamanickam Rajkumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6421",title:"Cervical Cancer",subtitle:"Screening, Treatment and Prevention - Universal Protocols for Ultimate Control",isOpenForSubmission:!1,hash:"33de90dc3727148b27fc60f4e46f92eb",slug:"cervical-cancer-screening-treatment-and-prevention-universal-protocols-for-ultimate-control",bookSignature:"Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/6421.jpg",editedByType:"Edited by",editors:[{id:"120109",title:"Dr.",name:"Rajamanickam",surname:"Rajkumar",slug:"rajamanickam-rajkumar",fullName:"Rajamanickam Rajkumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8946",title:"Human Papillomavirus",subtitle:null,isOpenForSubmission:!1,hash:"dcd959bb940ca13a13e234d6c569c06d",slug:"human-papillomavirus",bookSignature:"Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/8946.jpg",editedByType:"Edited by",editors:[{id:"120109",title:"Dr.",name:"Rajamanickam",surname:"Rajkumar",slug:"rajamanickam-rajkumar",fullName:"Rajamanickam Rajkumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"684",title:"Endometriosis",subtitle:"Basic Concepts and Current Research Trends",isOpenForSubmission:!1,hash:"1f5625375189846e4fa04200c135afcc",slug:"endometriosis-basic-concepts-and-current-research-trends",bookSignature:"Koel Chaudhury and Baidyanath Chakravarty",coverURL:"https://cdn.intechopen.com/books/images_new/684.jpg",editedByType:"Edited by",editors:[{id:"83747",title:"Prof.",name:"Koel",surname:"Chaudhury",slug:"koel-chaudhury",fullName:"Koel Chaudhury"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"707",title:"Hysterectomy",subtitle:null,isOpenForSubmission:!1,hash:"219d88512350b2e1d01cfd8faf81aa9c",slug:"hysterectomy",bookSignature:"Ayman Al-Hendy and Mohamed Sabry",coverURL:"https://cdn.intechopen.com/books/images_new/707.jpg",editedByType:"Edited by",editors:[{id:"54087",title:"Dr.",name:"Ayman",surname:"Al-Hendy",slug:"ayman-al-hendy",fullName:"Ayman Al-Hendy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1900",title:"In Vitro Fertilization",subtitle:"Innovative Clinical and Laboratory Aspects",isOpenForSubmission:!1,hash:"212b5ed00828501488c8d7025d84a188",slug:"in-vitro-fertilization-innovative-clinical-and-laboratory-aspects",bookSignature:"Shevach Friedler",coverURL:"https://cdn.intechopen.com/books/images_new/1900.jpg",editedByType:"Edited by",editors:[{id:"111647",title:"Prof.",name:"Shevach",surname:"Friedler",slug:"shevach-friedler",fullName:"Shevach Friedler"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6152",title:"Debatable Topics in PCOS Patients",subtitle:null,isOpenForSubmission:!1,hash:"c47a69bf2dac1f402c7f1b5751f1ea7e",slug:"debatable-topics-in-pcos-patients",bookSignature:"Neeraj Kumar Agrawal and Kiran Singh",coverURL:"https://cdn.intechopen.com/books/images_new/6152.jpg",editedByType:"Edited by",editors:[{id:"136647",title:"Dr.",name:"N.K.",surname:"Agrawal",slug:"n.k.-agrawal",fullName:"N.K. Agrawal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4641",title:"Approaches to Hysterectomy",subtitle:null,isOpenForSubmission:!1,hash:"a2a63bba8f7b17c10aff3d6d59ea0d08",slug:"approaches-to-hysterectomy",bookSignature:"Zouhair O. Amarin",coverURL:"https://cdn.intechopen.com/books/images_new/4641.jpg",editedByType:"Edited by",editors:[{id:"101551",title:"Prof.",name:"Zouhair",surname:"Amarin",slug:"zouhair-amarin",fullName:"Zouhair Amarin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6278",title:"Pelvic Floor Disorders",subtitle:null,isOpenForSubmission:!1,hash:"e53630ad8f02658c6ca31163f9d68193",slug:"pelvic-floor-disorders",bookSignature:"Raheela M. Rizvi",coverURL:"https://cdn.intechopen.com/books/images_new/6278.jpg",editedByType:"Edited by",editors:[{id:"185970",title:"Dr.",name:"Raheela",surname:"Rizvi",slug:"raheela-rizvi",fullName:"Raheela Rizvi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"67322",slug:"corrigendum-to-sexual-dysfunction-in-patients-with-systemic-sclerosis",title:"Corrigendum to: Sexual Dysfunction in Patients with Systemic Sclerosis",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/67322.pdf",downloadPdfUrl:"/chapter/pdf-download/67322",previewPdfUrl:"/chapter/pdf-preview/67322",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/67322",risUrl:"/chapter/ris/67322",chapter:{id:"66966",slug:"sexual-dysfunction-in-patients-with-systemic-sclerosis",signatures:"Barbora Heřmánková",dateSubmitted:"July 16th 2018",dateReviewed:"April 5th 2019",datePrePublished:"May 3rd 2019",datePublished:null,book:{id:"8269",title:"New Insights into Systemic Sclerosis",subtitle:null,fullTitle:"New Insights into Systemic Sclerosis",slug:"new-insights-into-systemic-sclerosis",publishedDate:"September 18th 2019",bookSignature:"Michal Tomcik",coverURL:"https://cdn.intechopen.com/books/images_new/8269.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"193284",title:"Dr.",name:"Michal",middleName:null,surname:"Tomcik",slug:"michal-tomcik",fullName:"Michal Tomcik"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null}},chapter:{id:"66966",slug:"sexual-dysfunction-in-patients-with-systemic-sclerosis",signatures:"Barbora Heřmánková",dateSubmitted:"July 16th 2018",dateReviewed:"April 5th 2019",datePrePublished:"May 3rd 2019",datePublished:null,book:{id:"8269",title:"New Insights into Systemic Sclerosis",subtitle:null,fullTitle:"New Insights into Systemic Sclerosis",slug:"new-insights-into-systemic-sclerosis",publishedDate:"September 18th 2019",bookSignature:"Michal Tomcik",coverURL:"https://cdn.intechopen.com/books/images_new/8269.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"193284",title:"Dr.",name:"Michal",middleName:null,surname:"Tomcik",slug:"michal-tomcik",fullName:"Michal Tomcik"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null},book:{id:"8269",title:"New Insights into Systemic Sclerosis",subtitle:null,fullTitle:"New Insights into Systemic Sclerosis",slug:"new-insights-into-systemic-sclerosis",publishedDate:"September 18th 2019",bookSignature:"Michal Tomcik",coverURL:"https://cdn.intechopen.com/books/images_new/8269.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"193284",title:"Dr.",name:"Michal",middleName:null,surname:"Tomcik",slug:"michal-tomcik",fullName:"Michal Tomcik"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"8032",leadTitle:null,title:"Staphylococcus and Streptococcus",subtitle:null,reviewType:"peer-reviewed",abstract:"Staphylococcus spp. and Streptococcus spp. have not only got pathogenic isolates, but also non-pathogenic isolates. Staphylococcus spp. and Streptococcus spp. that are Gram positive cocci are the main pathogens in several infections. Virulence factors such as usual and unusual surface proteins encoded by resistance genes are the main causes of pathogenesis. Multidrug-resistant pathogens that are the main causes of morbidity and mortality worldwide have the ability to synthesize a number of destructive enzymes encoded by resistance genes such as ?-lactamases. Resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pneumoniae, Group A, and Group B Streptococcus have emerged throughout the world. To eliminate these resistant pathogens that cause untreatable, acute, and chronic infections, different new antimicrobials must be developed and used. The goal of this book is to provide the latest information about the above topics.",isbn:"978-1-78984-473-3",printIsbn:"978-1-78984-472-6",pdfIsbn:"978-1-78985-941-6",doi:"10.5772/intechopen.77863",price:119,priceEur:129,priceUsd:155,slug:"staphylococcus-and-streptococcus",numberOfPages:120,isOpenForSubmission:!1,hash:"b9ddbf132ac8ea9d2a7613836e5a27ca",bookSignature:"Sahra Kırmusaoğlu",publishedDate:"March 11th 2020",coverURL:"https://cdn.intechopen.com/books/images_new/8032.jpg",keywords:null,numberOfDownloads:2489,numberOfWosCitations:0,numberOfCrossrefCitations:1,numberOfDimensionsCitations:1,numberOfTotalCitations:2,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"October 24th 2018",dateEndSecondStepPublish:"January 29th 2019",dateEndThirdStepPublish:"March 30th 2019",dateEndFourthStepPublish:"June 18th 2019",dateEndFifthStepPublish:"August 17th 2019",remainingDaysToSecondStep:"2 years",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:"Edited by",kuFlag:!1,biosketch:null,coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"179460",title:"Dr.",name:"Sahra",middleName:null,surname:"Kırmusaoğlu",slug:"sahra-kirmusaoglu",fullName:"Sahra Kırmusaoğlu",profilePictureURL:"https://mts.intechopen.com/storage/users/179460/images/system/179460.jpeg",biography:"Dr. Kırmusaoğlu, PhD, is an assistant professor of Microbiology\nat the Department of Molecular Biology and Genetics, T.C. Haliç\nUniversity. She specialized in Microbiology at Abant Izzet Baysal\nUniversity (Biology Department), Turkey. Her previous experience\nincludes laboratory manager at microbiology laboratories in several\nresearch and private hospitals. Throughout her career, she collaborated\nwith academicians/researchers from Abant Izzate Baysal University (AIBU), Middle East Technical University (METU), and Istanbul\nUniversity Cerrahpaşa Faculty of Medicine, and has participated in various research projects.\nDr. Kırmusaoğlu’s research interests include medical microbiology, pathogenic bacteria, bacterial biofilms, antibiofilm and antibacterial activity, bacterial drug resistance, pathogen–host interactions, pathogenesis, molecular microbiology, and microbiota. She has published several international research articles, books, book chapters, and congress proceedings.\nShe is also the editor of Disinfection, Bacterial Pathogenesis and Antibacterial Control,\nand Antimicrobials, Antibiotic Resistance, Antibiofilm Strategies and Activity Methods\npublished by IntechOpen. In addition to these, she wrote the book Genel Biyoloji Laboratuvar\nKılavuzu (General Biology Laboratory Manual) published by Hipokrat Publisher.\nShe has contributed to a chapter translation of the book Sherris Medical Microbiology\nby Ryan et al. as one of the translation authors of Sherris Tıbbi Mikrobiyoloji, which is a\nTurkish translated book edited by Prof. Dr. Dürdal Us and Prof. Dr. Ahmet Başustaoğlu.",institutionString:"Haliç University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"6",totalChapterViews:"0",totalEditedBooks:"5",institution:{name:"Haliç University",institutionURL:null,country:{name:"Turkey"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"409",title:"Bacteriology",slug:"biochemistry-genetics-and-molecular-biology-microbiology-bacteriology"}],chapters:[{id:"70748",title:"Introductory Chapter: An Overview of the Genus Staphylococcus and Streptococcus",slug:"introductory-chapter-an-overview-of-the-genus-em-staphylococcus-em-and-em-streptococcus-em-",totalDownloads:273,totalCrossrefCites:0,authors:[{id:"179460",title:"Dr.",name:"Sahra",surname:"Kırmusaoğlu",slug:"sahra-kirmusaoglu",fullName:"Sahra Kırmusaoğlu"}]},{id:"66603",title:"Virulence Factors of Streptococcus mutans Related to Dental Caries",slug:"virulence-factors-of-em-streptococcus-mutans-em-related-to-dental-caries",totalDownloads:384,totalCrossrefCites:0,authors:[{id:"282054",title:"Ph.D.",name:"María Alejandra",surname:"Bojanich",slug:"maria-alejandra-bojanich",fullName:"María Alejandra Bojanich"},{id:"292367",title:"Mr.",name:"Mariano Daniel",surname:"Orlietti",slug:"mariano-daniel-orlietti",fullName:"Mariano Daniel Orlietti"}]},{id:"68220",title:"Toward Better Understanding on How Group A Streptococcus Manipulates Human Fibrinolytic System",slug:"toward-better-understanding-on-how-group-a-em-streptococcus-em-manipulates-human-fibrinolytic-system",totalDownloads:240,totalCrossrefCites:0,authors:[{id:"290636",title:"Dr.",name:"Ruby",surname:"Law",slug:"ruby-law",fullName:"Ruby Law"},{id:"300264",title:"Dr.",name:"Adam J.",surname:"Quek",slug:"adam-j.-quek",fullName:"Adam J. Quek"},{id:"300265",title:"Prof.",name:"James C.",surname:"Whisstock",slug:"james-c.-whisstock",fullName:"James C. Whisstock"}]},{id:"70554",title:"Cell Surface and Cytosolic Proteins of Group B Streptococcus Adding New Dimensions in Its Colonization and Pathogenesis",slug:"cell-surface-and-cytosolic-proteins-of-group-b-streptococcus-adding-new-dimensions-in-its-colonizati",totalDownloads:223,totalCrossrefCites:0,authors:[{id:"287626",title:"Dr.",name:"Manju",surname:"Pai",slug:"manju-pai",fullName:"Manju Pai"},{id:"295422",title:"Dr.",name:"Venkatesh",surname:"S Pai",slug:"venkatesh-s-pai",fullName:"Venkatesh S Pai"},{id:"295423",title:"Prof.",name:"Pratima",surname:"Gupta",slug:"pratima-gupta",fullName:"Pratima Gupta"},{id:"295424",title:"Prof.",name:"Anuradha",surname:"Chakraborti",slug:"anuradha-chakraborti",fullName:"Anuradha Chakraborti"}]},{id:"68429",title:"Nemonoxacin (Taigexyn®): A New Non-Fluorinated Quinolone",slug:"nemonoxacin-taigexyn-sup-sup-a-new-non-fluorinated-quinolone",totalDownloads:305,totalCrossrefCites:0,authors:[{id:"284129",title:"Dr.",name:"Ming-Chu",surname:"Hsu",slug:"ming-chu-hsu",fullName:"Ming-Chu Hsu"},{id:"290925",title:"Prof.",name:"Ying-Yuan",surname:"Zhang",slug:"ying-yuan-zhang",fullName:"Ying-Yuan Zhang"},{id:"290926",title:"MSc.",name:"Li-Wen",surname:"Chang",slug:"li-wen-chang",fullName:"Li-Wen Chang"}]},{id:"66903",title:"Staphylococcus aureus in the Meat Supply Chain: Detection Methods, Antimicrobial Resistance, and Virulence Factors",slug:"-em-staphylococcus-aureus-em-in-the-meat-supply-chain-detection-methods-antimicrobial-resistance-and",totalDownloads:730,totalCrossrefCites:0,authors:[{id:"282838",title:"Ph.D.",name:"Valeria",surname:"Velasco",slug:"valeria-velasco",fullName:"Valeria Velasco"},{id:"289945",title:"Dr.",name:"Helia",surname:"Bello",slug:"helia-bello",fullName:"Helia Bello"},{id:"289946",title:"BSc.",name:"Mario",surname:"Quezada-Aguiluz",slug:"mario-quezada-aguiluz",fullName:"Mario Quezada-Aguiluz"}]},{id:"68398",title:"An Emerging Multidrug-Resistant Pathogen: Streptococcus pneumoniae",slug:"an-emerging-multidrug-resistant-pathogen-em-streptococcus-pneumoniae-em-",totalDownloads:335,totalCrossrefCites:1,authors:[{id:"291217",title:"Dr.",name:"Razique",surname:"Anwer",slug:"razique-anwer",fullName:"Razique Anwer"},{id:"291219",title:"Dr.",name:"Khalid",surname:"Alqumaizi",slug:"khalid-alqumaizi",fullName:"Khalid Alqumaizi"}]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"280415",firstName:"Josip",lastName:"Knapic",middleName:null,title:"Mr.",imageUrl:"https://mts.intechopen.com/storage/users/280415/images/8050_n.jpg",email:"josip@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copy-editing and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"8133",title:"Pathogenic Bacteria",subtitle:null,isOpenForSubmission:!1,hash:"b26e69f94525a38ead8ac88e3c68631a",slug:"pathogenic-bacteria",bookSignature:"Sahra Kırmusaoğlu and Sonia Bhonchal Bhardwaj",coverURL:"https://cdn.intechopen.com/books/images_new/8133.jpg",editedByType:"Edited by",editors:[{id:"179460",title:"Dr.",name:"Sahra",surname:"Kırmusaoğlu",slug:"sahra-kirmusaoglu",fullName:"Sahra Kırmusaoğlu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6148",title:"Bacterial Pathogenesis and Antibacterial Control",subtitle:null,isOpenForSubmission:!1,hash:"92128a5094670f6b0c9321640f60d3a3",slug:"bacterial-pathogenesis-and-antibacterial-control",bookSignature:"Sahra",coverURL:"https://cdn.intechopen.com/books/images_new/6148.jpg",editedByType:"Edited by",editors:[{id:"179460",title:"Dr.",name:"Sahra",surname:"Kırmusaoğlu",slug:"sahra-kirmusaoglu",fullName:"Sahra Kırmusaoğlu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8427",title:"Antimicrobials, Antibiotic Resistance, Antibiofilm Strategies and Activity Methods",subtitle:null,isOpenForSubmission:!1,hash:"0fdedc9bf6c23241235a0ae011c0304c",slug:"antimicrobials-antibiotic-resistance-antibiofilm-strategies-and-activity-methods",bookSignature:"Sahra Kırmusaoğlu",coverURL:"https://cdn.intechopen.com/books/images_new/8427.jpg",editedByType:"Edited by",editors:[{id:"179460",title:"Dr.",name:"Sahra",surname:"Kırmusaoğlu",slug:"sahra-kirmusaoglu",fullName:"Sahra Kırmusaoğlu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6601",title:"Disinfection",subtitle:null,isOpenForSubmission:!1,hash:"ea121cf9b26d006bc6d7c7f92195852d",slug:"disinfection",bookSignature:"Sahra Kırmusaoğlu",coverURL:"https://cdn.intechopen.com/books/images_new/6601.jpg",editedByType:"Edited by",editors:[{id:"179460",title:"Dr.",name:"Sahra",surname:"Kırmusaoğlu",slug:"sahra-kirmusaoglu",fullName:"Sahra Kırmusaoğlu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2796",title:"Lactic Acid Bacteria",subtitle:"R & D for Food, Health and Livestock Purposes",isOpenForSubmission:!1,hash:"8d625f084ccba1e96cc326406074fe3f",slug:"lactic-acid-bacteria-r-d-for-food-health-and-livestock-purposes",bookSignature:"Marcelino Kongo",coverURL:"https://cdn.intechopen.com/books/images_new/2796.jpg",editedByType:"Edited by",editors:[{id:"138356",title:"Dr.",name:"J. Marcelino",surname:"Kongo",slug:"j.-marcelino-kongo",fullName:"J. Marcelino Kongo"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2129",title:"A Search for Antibacterial Agents",subtitle:null,isOpenForSubmission:!1,hash:"1567c6402f459b018a6aabfd620aa3f7",slug:"a-search-for-antibacterial-agents",bookSignature:"Varaprasad Bobbarala",coverURL:"https://cdn.intechopen.com/books/images_new/2129.jpg",editedByType:"Edited by",editors:[{id:"90574",title:"Dr.",name:"Varaprasad",surname:"Bobbarala",slug:"varaprasad-bobbarala",fullName:"Varaprasad Bobbarala"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5056",title:"Actinobacteria",subtitle:"Basics and Biotechnological Applications",isOpenForSubmission:!1,hash:"46638f9636540f83f06226bf0e0a1e43",slug:"actinobacteria-basics-and-biotechnological-applications",bookSignature:"Dharumadurai Dhanasekaran and Yi Jiang",coverURL:"https://cdn.intechopen.com/books/images_new/5056.jpg",editedByType:"Edited by",editors:[{id:"48914",title:"Dr.",name:"Dharumadurai",surname:"Dhanasekaran",slug:"dharumadurai-dhanasekaran",fullName:"Dharumadurai Dhanasekaran"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5867",title:"Antibacterial Agents",subtitle:null,isOpenForSubmission:!1,hash:"7834e622de76478416bdc3092c52cb15",slug:"antibacterial-agents",bookSignature:"Ranjith N. Kumavath",coverURL:"https://cdn.intechopen.com/books/images_new/5867.jpg",editedByType:"Edited by",editors:[{id:"163692",title:"Dr.",name:"Ranjith",surname:"Kumavath",slug:"ranjith-kumavath",fullName:"Ranjith Kumavath"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"554",title:"Bacterial Artificial Chromosomes",subtitle:null,isOpenForSubmission:!1,hash:"3092adcfb46acf538c9ef38530f92d8f",slug:"bacterial-artificial-chromosomes",bookSignature:"Pradeep Chatterjee",coverURL:"https://cdn.intechopen.com/books/images_new/554.jpg",editedByType:"Edited by",editors:[{id:"91537",title:"Dr.",name:"Pradeep",surname:"Chatterjee",slug:"pradeep-chatterjee",fullName:"Pradeep Chatterjee"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6764",title:"Cyanobacteria",subtitle:null,isOpenForSubmission:!1,hash:"87c7d8f86f7c1185aa4dd47c6492951a",slug:"cyanobacteria",bookSignature:"Archana Tiwari",coverURL:"https://cdn.intechopen.com/books/images_new/6764.jpg",editedByType:"Edited by",editors:[{id:"186791",title:"Dr.",name:"Archana",surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"12160",title:"Properties and Function of Pyomelanin",doi:"10.5772/10273",slug:"properties-and-function-of-pyomelanin",body:null,keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/12160.pdf",chapterXML:null,downloadPdfUrl:"/chapter/pdf-download/12160",previewPdfUrl:"/chapter/pdf-preview/12160",totalDownloads:5427,totalViews:325,totalCrossrefCites:11,totalDimensionsCites:18,hasAltmetrics:0,dateSubmitted:null,dateReviewed:null,datePrePublished:null,datePublished:"September 28th 2010",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/12160",risUrl:"/chapter/ris/12160",book:{slug:"biopolymers"},signatures:"C.E. Turick, A.S. Knox, J.M. Becnel, A.A. Ekechukwu and C.E. Milliken",authors:null,sections:null,chapterReferences:null,footnotes:null,contributors:null,corrections:null},book:{id:"3659",title:"Biopolymers",subtitle:null,fullTitle:"Biopolymers",slug:"biopolymers",publishedDate:"September 28th 2010",bookSignature:"Magdy Elnashar",coverURL:"https://cdn.intechopen.com/books/images_new/3659.jpg",licenceType:"CC BY-NC-SA 3.0",editedByType:"Edited by",editors:[{id:"12075",title:"Prof.",name:"Magdy",middleName:null,surname:"Elnashar",slug:"magdy-elnashar",fullName:"Magdy Elnashar"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"12138",title:"Low-Cost Foods and Drugs Using Immobilized Enzymes on Biopolymers",slug:"low-cost-foods-and-drugs-using-immobilized-enzymes-on-biopolymers",totalDownloads:6813,totalCrossrefCites:2,signatures:"Magdy Elnashar",authors:[null]},{id:"12139",title:"Biomedical-Grade Chitosan in Wound Management and Its Biocompatibility In Vitro",slug:"biomedical-grade-chitosan-in-wound-management-and-its-biocompatibility-in-vitro",totalDownloads:5945,totalCrossrefCites:0,signatures:"Ahmad Sukari Halim and Chin Keong Lim",authors:[null]},{id:"12140",title:"Biopolymer-based Stimuli-Responsive Polymeric Systems for Functional Finishing of Textiles",slug:"biopolymer-based-stimuli-responsive-polymeric-systems-for-functional-finishing-of-textiles",totalDownloads:4217,totalCrossrefCites:5,signatures:"Dragan Jocic, Audrey Tourrette and Pavla Krizman Lavric",authors:[null]},{id:"12141",title:"Production of Biopolymer Composites by Particle Bonding",slug:"production-of-biopolymer-composites-by-particle-bonding",totalDownloads:3476,totalCrossrefCites:0,signatures:"Sanghoon Kim",authors:[null]},{id:"12142",title:"Life Span of Biopolymer Sequestering Agents for Contaminant Removal and Erosion Resistance",slug:"life-span-of-novel-biopolymer-sequestering-agents-for-organic-and-inorganic-contaminants-",totalDownloads:2643,totalCrossrefCites:3,signatures:"A.S. Knox, I.G. Petrisor, C.E. Turick, J. Roberts, M.H. Paller, D.D. Reible and C.R. Forrest",authors:[null]},{id:"12143",title:"Microfoams of Biopolymers by Laser-Induced Stretching: Mechanisms and Applications",slug:"microfoams-of-biopolymers-by-laser-induced-stretching-mechanisms-and-applications",totalDownloads:2438,totalCrossrefCites:2,signatures:"Sylvain Lazare",authors:[null]},{id:"12144",title:"Production of Fungal Chitosan by Enzymatic Method and Applications in Plant Tissue Culture and Tissue Engineering: 11 Years of Our Progress, Present Situation and Future Prospects",slug:"production-of-fungal-chitosan-by-enzymatic-method-and-applications-in-plant-tissue-culture-and-tissu",totalDownloads:9945,totalCrossrefCites:2,signatures:"Nitar Nwe, Tetsuya Furuike and Hiroshi Tamura",authors:[null]},{id:"12145",title:"Chitin Based Biocomposites for Removal of Contaminants from Water: a Case Study of Fluoride Adsorption",slug:"chitin-based-biocomposites-for-removal-of-contaminants-from-water-a-case-study-of-fluoride-adsorptio",totalDownloads:5596,totalCrossrefCites:0,signatures:"Jose Rene Rangel-Mendez, Vladimir Alonso Escobar Barrios and Jose Luis Davila-Rodriguez",authors:[null]},{id:"12146",title:"Cellulose Fibres Funcionalised by Chitosan: Characterization and Application",slug:"cellulose-fibres-functionalised-by-chitosan-characterization-and-application",totalDownloads:7925,totalCrossrefCites:6,signatures:"Simona Strnad, Olivera Sauperl and Lidija Fras-Zemljic",authors:[null]},{id:"12147",title:"Chitosan Based Membranes for Separation, Pervaporation and Fuel Cell Applications: Recent Developments",slug:"chitosan-based-membranes-",totalDownloads:8481,totalCrossrefCites:3,signatures:"Tina Chakrabarty, Mahendra Kumar and Vinod K. Shahi",authors:[null]},{id:"12148",title:"Fabrication of HA/PLLA Composite Scaffolds for Bone Tissue Engineering Using Additive Manufacturing Technologies",slug:"fabrication-of-ha-plla-composite-scaffolds-for-bone-tissue-engineering-using-additive-manufacturing-",totalDownloads:5311,totalCrossrefCites:8,signatures:"Fernando Cruz",authors:[null]},{id:"12149",title:"PEGylation and BioPEGylation of Polyhydroxyalkanoates: Synthesis, Characterisation and Applications",slug:"pegylation-and-biopegylation-of-polyhydroxyalkanoates-synthesis-characterisation-and-applications",totalDownloads:3667,totalCrossrefCites:3,signatures:"Leslie John Ray Foster",authors:[null]},{id:"12150",title:"Lubrication and Adhesion by Charged Biopolymers for Biomedical Applications",slug:"lubrication-and-adhesion-by-charged-biopolymers-for-biomedical-applications",totalDownloads:3833,totalCrossrefCites:0,signatures:"Roberto Andresen Eguiluz, Rebecca Schur and Delphine Gourdon",authors:[null]},{id:"12151",title:"The Role of Biofilm Exopolysaccharides on Biocontrol of Plant Diseases",slug:"the-role-of-biofilm-exopolysaccharides-on-biocontrol-of-plant-diseases",totalDownloads:4121,totalCrossrefCites:4,signatures:"Wafaa Haggag",authors:[null]},{id:"12152",title:"Bacterial Type II PMIs: Exploitable Bifunctional Enzymes for Biotechnological Applications and the Rational Design of Antimicrobials",slug:"bacterial-type-ii-pmis-exploitable-bifunctional-enzymes-for-biotechnological-applications-and-the-ra",totalDownloads:2172,totalCrossrefCites:0,signatures:"Sílvia Sousa, Christian Ramos, Joana Feliciano and Jorge Leitão",authors:[null]},{id:"12153",title:"Thermal Degradation of Lignocellulosic Fuels: Biopolymers Contribution",slug:"thermal-degradation-of-lignocellulosic-fuels-biopolymers-contribution-",totalDownloads:3734,totalCrossrefCites:1,signatures:"Valérie Leroy, Eric Leoni and Dominique Cancellieri",authors:[null]},{id:"12154",title:"Functional Properties of Some Non-Conventional Treated Starches",slug:"functional-properties-of-some-non-conventional-treated-starches",totalDownloads:4102,totalCrossrefCites:3,signatures:"Monica Nemtanu and Mirela Brasoveanu",authors:[null]},{id:"12155",title:"Bacterial Cellulose-based Biomimetic Composites",slug:"bacterial-cellulose-based-biomimetic-composites",totalDownloads:5953,totalCrossrefCites:5,signatures:"Thi Thi Nge, Junji Sugiyama and Vincent Bulone",authors:[null]},{id:"12156",title:"Precise Depolymerization of Poly(3-hydoxybutyrate) by Pyrolysis",slug:"precise-depolymerization-of-poly-3-hydoxybutyrate-by-pyrolysis",totalDownloads:3595,totalCrossrefCites:2,signatures:"Haruo Nishida, Hidayah Ariffin, Yoshihito Shirai and Mohd Hassan",authors:[null]},{id:"12157",title:"Biotechnological Production and Application of Hyaluronan",slug:"biotechnological-production-characterization-and-application-of-hyaluronan",totalDownloads:13763,totalCrossrefCites:14,signatures:"Chiara Schiraldi, Annalisa La Gatta and Mario De Rosa",authors:[null]},{id:"12158",title:"Biopolymers by Azotobacter Vinelandii",slug:"biopolymers-by-azotobacter-vinelandii",totalDownloads:6739,totalCrossrefCites:0,signatures:"Adriana Navarro da Silva and Crispin Humberto Garcia-Cruz",authors:[null]},{id:"12159",title:"Biopolymer Surfactant Interactions",slug:"biopolymer-surfactant-interactions",totalDownloads:4177,totalCrossrefCites:0,signatures:"Lisa Sreejith, S.M. Nair and Jinu George",authors:[null]},{id:"12160",title:"Properties and Function of Pyomelanin",slug:"properties-and-function-of-pyomelanin",totalDownloads:5427,totalCrossrefCites:11,signatures:"C.E. Turick, A.S. Knox, J.M. Becnel, A.A. Ekechukwu and C.E. Milliken",authors:[null]},{id:"12161",title:"Microbial Biopolimerization Production from Palm Oil Mill Effluent (POME)",slug:"microbial-biopolimerization-production-from-palm-oil-mill-effluent-pome-",totalDownloads:8377,totalCrossrefCites:3,signatures:"Zaini Ujang, Salmiati Salmiati and Mohd Razman Salim",authors:[null]},{id:"12162",title:"Calculation of Relaxation Spectra from Stress Relaxation Measurements",slug:"calculation-of-relaxation-spectra-from-stress-relaxation-measurements",totalDownloads:5353,totalCrossrefCites:1,signatures:"Vassilis Kontogiorgos",authors:[null]},{id:"12163",title:"Fluctuations of Stiff Polymers and Cell Mechanics",slug:"fluctuations-of-stiff-polymers-and-cell-mechanics-",totalDownloads:2675,totalCrossrefCites:1,signatures:"Jens Glaser and Klaus Kroy",authors:[null]},{id:"12164",title:"Detect Structure Features of Asymmetric and Symmetric CH2 and CH3 Functional Groups and Their Ratio of Biopolymers within Intact Tissue in Complex Plant System Using Synchrotron FTIRM and DRIFT Molecular Spectroscopy",slug:"detect-structure-features-of-asymmetric-and-symmetric-ch2-and-ch3-functional-groups-and-their-ratio-",totalDownloads:5022,totalCrossrefCites:1,signatures:"Peiqiang Yu",authors:[null]},{id:"12165",title:"Molecularly Imprinted Polymers (PIMs) in Biomedical Applications",slug:"molecularly-imprinted-polymers-for-biomedical-applications",totalDownloads:11233,totalCrossrefCites:6,signatures:"Francesco Puoci, Giuseppe Cirillo, Manuela Curcio, Francesca Iemma, Ortensia Ilaria Parisi, Umile Gianfranco Spizzirri and Nevio Picci",authors:[null]},{id:"12166",title:"Retracted: Hydrogels as Potential Nano-Scale Drug Delivery Systems",slug:"hydrogels-as-potential-drug-delivery-systems",totalDownloads:8069,totalCrossrefCites:0,signatures:"Mohammad Reza Saboktakin",authors:[null]},{id:"12167",title:"Biopolymers for Military Use: Opportunities and Environment Implications - a Review",slug:"biopolymers-for-military-use-opportunities-and-environment-implications-a-review",totalDownloads:3533,totalCrossrefCites:2,signatures:"Teodora Zecheru",authors:[null]}]},relatedBooks:[{type:"book",id:"158",title:"Biotechnology of Biopolymers",subtitle:null,isOpenForSubmission:!1,hash:"7a592cb6d064b9cc8e99ea99aa09c942",slug:"biotechnology-of-biopolymers",bookSignature:"Magdy Elnashar",coverURL:"https://cdn.intechopen.com/books/images_new/158.jpg",editedByType:"Edited by",editors:[{id:"12075",title:"Prof.",name:"Magdy",surname:"Elnashar",slug:"magdy-elnashar",fullName:"Magdy Elnashar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"16195",title:"The Art of Immobilization Using Biopolymers, Biomaterials and Nanobiotechnology",slug:"the-art-of-immobilization-using-biopolymers-biomaterials-and-nanobiotechnology",signatures:"Magdy M.M. Elnashar",authors:[{id:"12075",title:"Prof.",name:"Magdy",middleName:null,surname:"Elnashar",fullName:"Magdy Elnashar",slug:"magdy-elnashar"}]},{id:"16196",title:"Polysaccharides from Wastes of Vegetable Industrial Processing: New Opportunities for Their Eco-Friendly Re-Use",slug:"polysaccharides-from-wastes-of-vegetable-industrial-processing-new-opportunities-for-their-eco-frien",signatures:"Annarita Poli, Gianluca Anzelmo,\nGabriella Fiorentino, Barbara Nicolaus, Giuseppina Tommonaro and Paola Di Donato",authors:[{id:"24920",title:"Dr.",name:"Annarita",middleName:null,surname:"Poli",fullName:"Annarita Poli",slug:"annarita-poli"},{id:"34892",title:"Dr",name:"Gianluca",middleName:null,surname:"Anzelmo",fullName:"Gianluca Anzelmo",slug:"gianluca-anzelmo"},{id:"34893",title:"Dr.",name:"Gabriella",middleName:null,surname:"Fiorentino",fullName:"Gabriella Fiorentino",slug:"gabriella-fiorentino"},{id:"34894",title:"Dr.",name:"Barbara",middleName:null,surname:"Nicolaus",fullName:"Barbara Nicolaus",slug:"barbara-nicolaus"},{id:"34895",title:"Dr.",name:"Paola",middleName:null,surname:"Di Donato",fullName:"Paola Di Donato",slug:"paola-di-donato"},{id:"71443",title:"Dr.",name:"Giuseppina",middleName:null,surname:"Tommonaro",fullName:"Giuseppina Tommonaro",slug:"giuseppina-tommonaro"}]},{id:"16197",title:"Conversion of Biomass into Bioplastics and Their Potential Environmental Impacts",slug:"conversion-of-biomass-into-bioplastics-and-their-potential-environmental-impacts",signatures:"Lei Pei, Markus Schmidt and Wei Wei",authors:[{id:"30214",title:"Dr.",name:"Markus",middleName:null,surname:"Schmidt",fullName:"Markus Schmidt",slug:"markus-schmidt"},{id:"30215",title:"Dr.",name:"Lei",middleName:null,surname:"Pei",fullName:"Lei Pei",slug:"lei-pei"},{id:"67408",title:"Dr.",name:"Wei",middleName:null,surname:"Wei",fullName:"Wei Wei",slug:"wei-wei"}]},{id:"16198",title:"Natural Rubber Biosynthesis and Physic-Chemical Studies on Plant Derived Latex",slug:"natural-rubber-biosynthesis-and-physic-chemical-studies-on-plant-derived-latex",signatures:"Christian Schulze Gronover, Daniela Wahler and Dirk Prüfer",authors:[{id:"27396",title:"Dr.",name:"Christian",middleName:null,surname:"Schulze Gronover",fullName:"Christian Schulze Gronover",slug:"christian-schulze-gronover"},{id:"35750",title:"Prof.",name:"Dirk",middleName:null,surname:"Prüfer",fullName:"Dirk Prüfer",slug:"dirk-prufer"},{id:"67031",title:"Dr.",name:"Daniela",middleName:null,surname:"Wahler",fullName:"Daniela Wahler",slug:"daniela-wahler"}]},{id:"16199",title:"Characterization and Properties of Chitosan",slug:"characterization-and-properties-of-chitosan",signatures:"Elson Santiago de Alvarenga",authors:[{id:"27012",title:"Dr",name:"Elson Santiago",middleName:null,surname:"de Alvarenga",fullName:"Elson Santiago de Alvarenga",slug:"elson-santiago-de-alvarenga"}]},{id:"16200",title:"The Development, Characterization and Application of Water Soluble Chitosan",slug:"the-development-characterization-and-application-of-water-soluble-chitosan",signatures:"Zanariah Ujang, Mazita Diah, Ahmad Hazri Abdul Rashid and Ahmad Sukari Halim",authors:[{id:"11999",title:"Prof.",name:"Ahmad Sukari",middleName:null,surname:"Halim",fullName:"Ahmad Sukari Halim",slug:"ahmad-sukari-halim"},{id:"26278",title:"Dr.",name:"Zanariah",middleName:null,surname:"Ujang",fullName:"Zanariah Ujang",slug:"zanariah-ujang"},{id:"34144",title:"Dr.",name:"Ahmad Hazri",middleName:null,surname:"Abdul Rashid",fullName:"Ahmad Hazri Abdul Rashid",slug:"ahmad-hazri-abdul-rashid"},{id:"34145",title:"MSc.",name:"Mazita",middleName:null,surname:"Mohd Diah",fullName:"Mazita Mohd Diah",slug:"mazita-mohd-diah"}]},{id:"16201",title:"Perspectives of Chitin Deacetylase Research",slug:"perspectives-of-chitin-deacetylase-research",signatures:"Yong Zhao, Wan-Taek Ju, Gyung-Hyun Jo, Woo-Jin Jung and Ro-Dong Park",authors:[{id:"33158",title:"Prof.",name:"Ro-Dong",middleName:null,surname:"Park",fullName:"Ro-Dong Park",slug:"ro-dong-park"},{id:"33159",title:"Dr.",name:"Yong",middleName:null,surname:"Zhao",fullName:"Yong Zhao",slug:"yong-zhao"},{id:"33160",title:"Prof.",name:"Woo-Jin",middleName:null,surname:"Jung",fullName:"Woo-Jin Jung",slug:"woo-jin-jung"},{id:"33161",title:"MSc.",name:"Wan-Taek",middleName:null,surname:"Ju",fullName:"Wan-Taek Ju",slug:"wan-taek-ju"},{id:"70190",title:"Dr.",name:"Gyung-Hyun",middleName:null,surname:"Jo",fullName:"Gyung-Hyun Jo",slug:"gyung-hyun-jo"},{id:"128151",title:"Prof.",name:"Yong",middleName:null,surname:"Zhao",fullName:"Yong Zhao",slug:"yong-zhao"},{id:"128152",title:"Prof.",name:"Wan-Taek",middleName:null,surname:"Ju",fullName:"Wan-Taek Ju",slug:"wan-taek-ju"},{id:"128153",title:"Prof.",name:"Woo-Jin",middleName:null,surname:"Jung",fullName:"Woo-Jin Jung",slug:"woo-jin-jung"}]},{id:"16202",title:"Mechanisms Controlling the Expression of the Exopolysaccharide of Burkholderia and Role in Niche Adaptation",slug:"mechanisms-controlling-the-expression-of-the-exopolysaccharide-of-burkholderia-and-role-in-niche-ada",signatures:"Ana S. Ferreira, Ines N. Silva and Leonilde M. Moreira",authors:[{id:"24717",title:"Dr.",name:"Leonilde",middleName:null,surname:"Moreira",fullName:"Leonilde Moreira",slug:"leonilde-moreira"},{id:"34604",title:"Dr.",name:"Ana Sofia",middleName:null,surname:"Ferreira",fullName:"Ana Sofia Ferreira",slug:"ana-sofia-ferreira"},{id:"34605",title:"MSc",name:"Inês",middleName:null,surname:"Silva",fullName:"Inês Silva",slug:"ines-silva"}]},{id:"16203",title:"Zimm-Bragg Model Applied to Sorption of Dyes by Biopolymers: Alginic Acid and Xanthan",slug:"zimm-bragg-model-applied-to-sorption-of-dyes-by-biopolymers-alginic-acid-and-xanthan",signatures:"Juan Jáuregui-Rincón, Juan Antonio Lozano-Alvarez and Iliana Medina-Ramírez",authors:[{id:"27175",title:"Prof.",name:"Juan",middleName:null,surname:"Jauregui-Rincon",fullName:"Juan Jauregui-Rincon",slug:"juan-jauregui-rincon"},{id:"31630",title:"Prof.",name:"Juan Antonio",middleName:null,surname:"Lozano-Alvarez",fullName:"Juan Antonio Lozano-Alvarez",slug:"juan-antonio-lozano-alvarez"},{id:"31631",title:"Prof.",name:"Iliana E.",middleName:null,surname:"Medina-Ramirez",fullName:"Iliana E. Medina-Ramirez",slug:"iliana-e.-medina-ramirez"}]},{id:"16204",title:"Macro and Micro Characterization of Biopolymers: Case of Cotton Fibre",slug:"macro-and-micro-characterization-of-biopolymers-case-of-cotton-fibre",signatures:"Omar Harzallah and Jean-Yves Drean",authors:[{id:"26432",title:"Prof.",name:"Omar",middleName:null,surname:"Harzallah",fullName:"Omar Harzallah",slug:"omar-harzallah"},{id:"36495",title:"Prof.",name:"Jean-Yves",middleName:null,surname:"Drean",fullName:"Jean-Yves Drean",slug:"jean-yves-drean"}]},{id:"16205",title:"SR-IMS Molecular Spectroscopic Image of Functional Groups in Biopolymers in Feed Systems",slug:"sr-ims-molecular-spectroscopic-image-of-functional-groups-in-biopolymers-in-feed-systems",signatures:"Peiqiang Yu",authors:[{id:"12680",title:"Prof.",name:"Peiqiang",middleName:null,surname:"Yu",fullName:"Peiqiang Yu",slug:"peiqiang-yu"}]},{id:"16206",title:"New Conceptions about Structure Formation of Biopolymers",slug:"new-conceptions-about-structure-formation-of-biopolymers",signatures:"Shabalkin I.P. and Shabalkin P.I.",authors:[{id:"31621",title:"Dr.",name:"Pavel",middleName:null,surname:"Shabalkin",fullName:"Pavel Shabalkin",slug:"pavel-shabalkin"},{id:"62794",title:"Dr.",name:"Igor",middleName:null,surname:"Shabalkin",fullName:"Igor Shabalkin",slug:"igor-shabalkin"}]},{id:"16207",title:"Activated Sugar Precursors: Biosynthetic Pathways and Biological Roles of an Important Class of Intermediate Metabolites in Bacteria",slug:"activated-sugar-precursors-biosynthetic-pathways-and-biological-roles-of-an-important-class-of-inter",signatures:"Sílvia A. Sousa, Joana R. Feliciano and Jorge H. Leitao",authors:[{id:"11792",title:"Prof.",name:"Jorge",middleName:"H",surname:"Leitão",fullName:"Jorge Leitão",slug:"jorge-leitao"},{id:"12411",title:"PhD",name:"Sílvia",middleName:null,surname:"Sousa",fullName:"Sílvia Sousa",slug:"silvia-sousa"},{id:"35701",title:"MSc.",name:"Joana",middleName:null,surname:"Feliciano",fullName:"Joana Feliciano",slug:"joana-feliciano"}]},{id:"16208",title:"Biofunctional Xerography",slug:"biofunctional-xerography",signatures:"Felix Loffler, Yun-Chien Cheng, Tobias Fortsch, Edgar Dorsam, Ralf Bischoff, Frank Breitling and Alexander Nesterov-Muller",authors:[{id:"24696",title:"Dr.",name:"Alexander",middleName:null,surname:"Nesterov-Müller",fullName:"Alexander Nesterov-Müller",slug:"alexander-nesterov-muller"},{id:"31846",title:"MSc.",name:"Felix",middleName:null,surname:"Löffler",fullName:"Felix Löffler",slug:"felix-loffler"},{id:"31847",title:"Mr.",name:"Yun-Chien",middleName:null,surname:"Cheng",fullName:"Yun-Chien Cheng",slug:"yun-chien-cheng"},{id:"31848",title:"Prof.",name:"Edgar",middleName:null,surname:"Dörsam",fullName:"Edgar Dörsam",slug:"edgar-dorsam"},{id:"31849",title:"Dr.",name:"Ralf",middleName:null,surname:"Bischoff",fullName:"Ralf Bischoff",slug:"ralf-bischoff"},{id:"31850",title:"Dr.",name:"Frank",middleName:null,surname:"Breitling",fullName:"Frank Breitling",slug:"frank-breitling"},{id:"65145",title:"Mr.",name:"Tobias",middleName:"Christoph",surname:"Förtsch",fullName:"Tobias Förtsch",slug:"tobias-fortsch"},{id:"124208",title:"BSc.",name:"Tobias",middleName:null,surname:"Förtsch",fullName:"Tobias Förtsch",slug:"tobias-fortsch"}]},{id:"16209",title:"Thermodynamics of Nucleic Acid Structural Modifications for Biotechnology Applications",slug:"thermodynamics-of-nucleic-acid-structural-modifications-for-biotechnology-applications",signatures:"Stefan Franzen",authors:[{id:"42669",title:"Dr.",name:"Stefan",middleName:null,surname:"Franzen",fullName:"Stefan Franzen",slug:"stefan-franzen"}]},{id:"16210",title:"Nutraceutical Properties of Milk Fat Globular Membrane",slug:"nutraceutical-properties-of-milk-fat-globular-membrane",signatures:"Korry J. Hintze, Dallin Snow, Ian Burtenshaw and Robert E. Ward",authors:[{id:"26133",title:"Dr.",name:"Korry",middleName:null,surname:"Hintze",fullName:"Korry Hintze",slug:"korry-hintze"},{id:"36109",title:"Dr.",name:"Robert",middleName:null,surname:"Ward",fullName:"Robert Ward",slug:"robert-ward"},{id:"80577",title:"Mr.",name:"Dallin",middleName:null,surname:"Snow",fullName:"Dallin Snow",slug:"dallin-snow"},{id:"82487",title:"Mr.",name:"Ian",middleName:null,surname:"Burtenshaw",fullName:"Ian Burtenshaw",slug:"ian-burtenshaw"},{id:"128158",title:"Prof.",name:"Dallin",middleName:null,surname:"Snow",fullName:"Dallin Snow",slug:"dallin-snow"}]},{id:"16211",title:"The Development of Novel In Vitro Binding Assays to Further Elucidate the Role of tRNAs in Protein Synthesis",slug:"the-development-of-novel-in-vitro-binding-assays-to-further-elucidate-the-role-of-trnas-in-protein-s",signatures:"Anthony J. Bell, Jr., Suzanna Ellzey,\nDevin McDougald and Crystal Serrano",authors:[{id:"44998",title:"Dr.",name:"Anthony",middleName:"Jerome",surname:"Bell, Jr.",fullName:"Anthony Bell, Jr.",slug:"anthony-bell-jr."},{id:"56078",title:"Ms.",name:"Crystal",middleName:null,surname:"Serrano",fullName:"Crystal Serrano",slug:"crystal-serrano"},{id:"56079",title:"Mr.",name:"Devin",middleName:null,surname:"McDougald",fullName:"Devin McDougald",slug:"devin-mcdougald"},{id:"56080",title:"Ms.",name:"Suzzan",middleName:null,surname:"Ellzey",fullName:"Suzzan Ellzey",slug:"suzzan-ellzey"},{id:"128159",title:"Prof.",name:"Anthony",middleName:null,surname:"Bell, Jr.",fullName:"Anthony Bell, Jr.",slug:"anthony-bell-jr."}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"72674",title:"Brachytherapy in Endometrial Cancer",doi:"10.5772/intechopen.92703",slug:"brachytherapy-in-endometrial-cancer",body:'Endometrial cancer is the most common gynecologic cancer in developed countries with the cumulative risk rate of 1.71% [1]. The median age at the time of diagnosis is 63 years and about 90% of the patients are above 50 years of age. However, 4% of the patients are diagnosed under the age of 40 years [2]. The vast majority (80%) of endometrial cancer patients are diagnosed at early stages and while the 5-year survival rate is 95%, it significantly decreases in patients with local and distant metastases (68 and 17%, respectively) [3]. The standard treatment of endometrial cancer is total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH + BSO). Lymphadenectomy is performed in suitable patients when indicated [4, 5]. Adjuvant radiotherapy may be recommended for patients in advanced age who have high-grade disease, deep myometrial invasion, LVSI positivity, risk factors such as large tumor diameter, lymph node invasion and advanced stage disease (Table 1)[6, 7, 8, 9].
PORTEC-1 | GOG 99 | |
---|---|---|
Age | >60 | See below |
Grad· | 3 | 2–3 |
Myometrial invasion | >50% (outer 1/2) | >66.6%·(outer 1/3) |
Lvmphvasctilar space invasion | N/A | Present |
High-intermediate risk group | At least 2/3 of above | any age, all three of above risk factors age > 50, two of above risk factors age > 70, one of above risk factors |
High-intermediate risk groups in FIGO stage I endometrial cancer as defined by PORTEC-1 and GOG 99.
FIGO, International Federation of Gynecology and Obstetrics; PORTEC, postoperative radiation therapy in endometrial cancer; GOG, gynecologic oncology group.
The risk groups had previously been addressed in many studies (PORTEC-1, GOG 99 studies) and finally a consensus was reached by the European Society For Medical Oncology (ESMO), European Society for Radiotherapy and Oncology (ESTRO) and the European Society Of Gynecological Oncology (ESGO) in 2014 (Table 2)[9].
Risk group | Description |
---|---|
Low | Stage I endometrioid, erade 1–2, <50% myometrial invasion, LVSI negative |
Intermediate | Stage I endometrioid, grade 1–2, ≥50% myometrial invasion, LVSI negative |
High-intermediate | Stage I endometrioid, grade 3, <50% myometrial invasion, regardless of LVSI status Stage I endometrioid. 1–2, LVSI unequivocally positive, regardless of depth of invasion |
High | Stage I endometrioid, grade 3, ≥50% myometrial invasion, regardless of LVSI status Stage II Stage III endometrioid. no residual disease Non-endometrioid (serous or clear cell or undifferentiated carcinoma, or carcinosarcoma) |
Advanced | Stage III residual disease and stage IVA |
Metastatic | Stage IVB |
New risk groups to guide adjuvant therapy use.
In the randomized controlled studies of GOG (Gynecological Oncology Group) 99 and PORTEC-1 (Operative Radiation Therapy in Endometrial Cancer), the patients who had intermediate risk factors were divided to two groups and while one group received external beam radiotherapy (EBRT), the other group was followed-up without treatment. The groups in both studies have been presented in Table 1 [6, 8].
No effect could be demonstrated on the overall survival in either of the two studies. However, the recurrence rate decreased to 3–6% from 12 to 15% in patients with intermediate risk factors who received EBRT. In the subgroup analyses, while the recurrence rate decreased to 5–6% from 18 to 26% in patients in the high-intermediate (H-I) risk group, it decreased to 2% from 5 to 6% in the low-intermediate risk group. Side effects of radiation therapy were seen at a high rate in both studies despite an excellent local control. While the toxic effect rate was 26% in the EBRT group in PORTEC 1, it was 4% in the untreated group (p < 0.0001) [10]. Hematological, genitor-urinary, gastro-intestinal and skin complications were also significantly higher in the GOG 99 study group compared to the untreated group [6]. In the long-term quality of life data of the PORTEC-1 study, urinary and intestinal functions were found to be poorer compared to the untreated group [11]. Local radiation therapies have come to the foreground due to the high incidence of the toxic effects of pelvic EBRT and their significance has gradually increased. Brachytherapy is applied in two ways, namely intra-cavitary or interstitial radiation therapy. Intra-cavitary brachytherapy is the presence of a therapeutic radioactive isotope within the body space, for example, vaginal and intra-uterine brachytherapy. Radioactive isotopes are directly inserted within the tissue in interstitial brachytherapy as in the treatment of cervical or endometrial cancers that have reached the lateral walls. The intra-cavitary brachytherapy technique is the most commonly used technique in gynecologic oncology.
Various vaginal applicators are available in gynecologic oncology depending on the location of the radiation source and whether it contains a cover or not. The Fletcher-Suit-Delclos system is among the most commonly used (Figure 1). Vaginal ring applicators are mostly used in HDR. Cylinder vaginal applicators, i.e., Delclos dome cylinder are used in patients undergoing hysterectomy (Figure 2).
Vaginal ring applicator.
Cylinder vaginal applicators (Delclos dome cylinder).
Single-channel cylinder applicator is among the most commonly used applicators; it minimizes the toxic effects as it is simple and since it covers the whole of the vaginal surface [12]. Multi-channel vaginal cylinder applicators are less harmful to neighboring tissues through providing asymmetrical dose radiation; however, they have a higher effect on the vaginal mucosa [13, 14].
Despite the presence of variable applicators, they have similar efficiency in the prevention of vaginal recurrence.
Despite the absence of a standard dose depth, vaginal lymphatics were reported to proceed 3 mm beneath the mucosa and treatment covering this depth was reported to be sufficient. Normally, a 1 cm depth is targeted. The most common monotherapy is a 0.5 cm depth and 7 Gy 3 fraction [12]. The doses effective in the vaginal surface when used as vaginal boost treatment have been reported by the Radiation Therapy Oncology Group [15].
There is no consensus on the vaginal length to be treated. It has been reported that the proximal vagina can be treated between 1 and 10 cm [16]. The American Brachytherapy Society (ABS) has reported that the proximal vagina should be treated 3–5 cm or including 1/2–1/3 of the vagina [17]. Due to the possibility of high toxic doses causing vaginal stenosis and due to the decreasing frequency of distal vaginal recurrence, the treatment modalities that cover the whole vagina are gradually decreasing [12].
All vaginal brachytherapy applications had been carried out as LDR before the introduction of HDR [4]. Historically, low dose hourly 60 cGy had been used widespread in most brachytherapy regimens. This treatment modality given as LDR was taking long and it required hospitalization. About 96% of brachy therapists have switched to this method through the introduction of HDR applicators [17]. The advantages of HDR include less radiation exposure of the health staff and visitors as it enables remote control, thrombo-embolic events are less frequently encountered as the patients are treated in the outpatient setting and long-term immobilization is avoided. There is no difference between LDR and HDR with regard to recurrence and the overall survival [18].
There are many ways for an accurate treatment plan in VB applications. When 2D and 3D CT-based treatment plans were compared, the 3D method was found to be superior as it reached the clinical target volume and produced less harm to neighboring tissues [19]. Many brachy therapists use the 3D treatment plan and its application at every session separately was not found to be superior to single session application, except for being expensive [20]. The CT-based treatment plan reveals the air between the vaginal cuff and the applicator effectively and enables a more effective treatment [21].
The toxic dose that emerges during VB is related to the amount of the total dose, dose velocity, total vaginal length, dose depth and the fraction time. In a study, the patients who received VB with HDR were allocated to four groups as 4 fractions of 9.0 Gy, 5 fractions of 6.0 Gy, 6 fractions of 5.0 Gy and 6 fractions of 4.5 Gy. A 1 cm depth from the vaginal surface was utilized. Vaginal, urinary bladder and rectal toxicity were found to increase as the amount of the dose increased along with the fraction [22]. In another study, no grade 2 or above vaginal, urinary bladder and rectal toxicity were encountered when 6 fractions of 4.0 Gy VB was applied targeted only to the vaginal surface [23]. The ABS recommends HDR VB as 24 treatment schemes as monotherapy and the 22 treatment scheme as boost dose [12]. In the PORTEC-4 study conducted for standardization of the dose and the fraction amount, the patients with H-I risk, early stage endometrial cancer were divided into treatment and observation groups; the treatment group was randomized as 3 fractions of 7.0 Gy or 3 fractions of 5.0 Gy. However, the study was terminated early as the patient collection and the untreated group were not proper. Therefore, further studies are required for standardization of the dose amount and the duration of fraction.
Vaginal toxicity is a significant complication of VB and it impairs the quality of sexual life due to vaginal atrophy, shortness and narrowness. The sexual activity frequency and satisfaction are reduced in patients undergoing surgery and VB [24]. In a study, having sexual intercourse during the VB treatment was reported to prevent vaginal shortness and narrowness; however, atrophy-related dyspareunia was reported in 2/3 of the patients and furthermore, it was emphasized that the distal 2/3 of the vagina was more susceptible to toxic effects rather than the proximal 1/3 of the vagina [22]. Use of vaginal dilator for 6 months following radiotherapy was shown to decrease the vaginal stenosis [25]. In the Cochrane database, use of vaginal dilator during radiotherapy was not shown to have sufficient evidence. However, it accepts the observational studies suggesting that use of the regular vaginal dilator may improve the vaginal stenosis rates reported by the patients [26]. Estrogen cream is another option for protection of the vagina. Despite the absence of sufficient and strong evidence about the use of estrogen creams, they were shown to prevent vaginal atrophy in small studies [27]. A selection should be made after discussing the benefits and harms of this treatment option with the patient.
As reported above, we know that pelvic EBRT reduces the recurrence; however, it leads to severe side effects compared to follow-up without treatment in endometrial cancer. Radiotherapy via the vaginal route was considered to be more proper as vaginal recurrences are seen most in post-operative endometrial cancer patients. Similarly, with pelvic EBRT, VB treatment was not shown to be effective on the overall survival. However, while the vaginal recurrence rate is 0–3.1% in VB, the pelvic recurrence rate is 0–4.1% [28, 29, 30]. These rates are similar with pelvic EBRT and related to the lower toxic effects.
In the randomized controlled PROTEC-2 study comparing the effectiveness of pelvic EBRT and VB treatment, all patients were H-I risk endometrial cancer patients who had undergone TAH + BSO, but not lymphadenectomy. The patients were allocated to three groups as the group that received 23 fractions 46 Gy as pelvic EBRT, the high dose rate (HDR) group that received 7 Gyx3 fractions and the low dose rate (LDR) group that received 30 Gy VB. While the 5-year vaginal recurrence was 1.8% with VB, it was 1.6% in the pelvic EBRT group (p = 0.74). The pelvic recurrence rate was higher in the VB group (3.8% vs. 0.5%, p = 0.02). However, the gastrointestinal side effects were significantly lower in the VB group compared to the EBRT group [30].
A better loco-regional control can be achieved by adding VB to pelvic EBRT and the rate of vaginal recurrence would be seen as 0–2.7% and the rate of pelvic recurrence as 0.3–4.0% [29, 31, 32, 33]. Despite the absence of EBRT+/-VB randomized controlled study, boost VB may be added in the treatment of high risk patients whose vaginal recurrence is high and who receive low dose EBRT (45 Gy at 1.8 Gy/fractions). There are randomized controlled studies comparing EBRT + boost VB and VB alone. In one of these studies, while the total pelvic recurrence rate was 0.4% in EBRT + boost VB group, it was 5.3% in the VB only group (p = 0.013). No difference was found between the groups with regard to vaginal recurrence and overall survival; however, the radiation toxicity was lower in the VB group [33]. In the studies of RTOG, applying 5–6 Gy VB boost only onto the vaginal surface as 45 Gy EBRTx3 fractions or 50.4 Gy EBRTx2 fractions is recommended [34, 35].
The effect of adding chemotherapy (CT) to VB was investigated particularly in high risk endometrial cancer patients who had the likelihood of distant metastasis. In a study conducted by Landrum et al., the 2-year progression-free survival was 91% in 23 patients including H-I risk early stage endometrial cancer, uterine serous carcinoma (USC) and clear cell carcinoma (CCC). Vaginal recurrence occurred in one patient (4.2%); this patient also had distant metastasis [36]. The effect of VB + CT was investigated in the GOG 249 randomized controlled study. In that study, while one group received EBRT, another group received VB + CT (3 cycles of carboplatin and paclitaxel). The study included the GOG 99 H-I risk patients, patients with stromal invasion and stage 1–2 USC and CCC. While the overall survival was 92% in the EBRT group, it was 92% in the VB + CT group at the end of the 2-year follow-up (p = NS). There was no significant difference between the vaginal recurrence rates in the two groups. While hematologic toxicity, neuropathy and fatigue were more common in the VB + CT arm, grade 2 diarrhea was more common in the EBRT arm [37].
More aggressive treatments are used in uterine serous cancer (USC), clear cell carcinoma (CCC) and carcino-sarcoma (CS), which are the high risk histologies of endometrial cancer [38]. Most of the large studies including PORTEC-1, GOG 99 and PORTEC-2 [6, 8, 30] included early stage endometrial cancer patients and not high-risk patients. However, in the GOG 249 study, 20% of the patients were USC and CCC patients [37]. In a study conducted by Creasman et al., the outcomes of stage 1 high risk patients were found to be similar to those of grade 3 endometrioid type adeno-carcinoma patients [39]. Despite the presence of vaginal recurrence at a rate of 0–2.7% in stage 1–2 patients with high risk histology, the pelvic recurrence rate was found to be 0–9% [40, 41, 42, 43]. In a study investigating USC patients, while the 5-year survival rate was 94% in patients who received VB + CT, it was 65% in patients who received LDR + EBRT but not CT [40]. In another study, USC patients received VB + CT (six cycles of carboplatin and paclitaxel) and the vaginal, pelvic and distant metastasis rates were found to be 0, 9, and 10%, respectively, and the 5-year survival rate was 90% [41]. The effectiveness of VB alone was investigated in endometrial cancer patients with high risk histology. Some authors reported that CT did not have a great contribution [42, 43].
As mentioned above, the standard treatment of endometrial cancer is TAH + BSO (total abdominal hysterectomy + bilateral salphingo-oopherectomy) and lymphadenectomy when indicated, however, this standard treatment cannot be performed in a group of patients due to their medical disorders and clinical performances. In these patients, definitive radiotherapy is applied for clinical stage 1 patients, neo-adjuvant therapy is applied to patients with local advanced stage disease and brachytherapy alone or radiotherapy with addition of EBRT is applied as palliative treatment in patients who have complaints such as bleeding and pelvic pain. While LDR VB+/−EBRT has been used recently in the treatment of these patients, HDR VB+/−EBRT is widely used today [44, 45]. The treatment of medically inoperable endometrial cancer patients is planned better and more effectively through advancements in radiology.
Medically inoperable endometrial cancer patients should be meticulously evaluated pre-operatively by a gynecologic oncologist. Most of these patients have cardiac diseases, pulmonary diseases, hypertension, diabetes mellitus, cerebro-vascular disease, renal disease, syndromes such as Marfan syndrome, advanced age and other malignancies. Morbid obesity is a relative contra-indication for the operation depending on the experience of the surgeon and the condition of the patient. Clinical performance of the patients is of vital importance as a pre-operative parameter. All of these patients should be evaluated pre-operatively for local or general anesthesia by experienced anesthetists. The hormone therapy (progestin, aromatase inhibitors) option is also available besides the radiotherapy option for clinical stage 1, grade 1 patients who are not eligible for surgery, for patients with endometrioid type endometrial cancer, for those below the age of 40 years and those willing to have a child [46]. Regression has been detected in 55% of the patients treated in this way [47].
Levonorgestrel-releasing intra-uterine devices (LNGIUDs) may be added to treatment of patients who have precancerous and stage 1, grade 1 endometrioid type endometrial cancer [48]. The patients are meticulously evaluated with CT or MRI with regard to tumor diameter, myometrial invasion depth, cervical involvement, ovarian involvement and pelvic para-aortic lymph node involvement if hormone therapy is planned, as oral regimens have the likelihood of recurrence at a rate of 25% despite the 50% or above success rates [49]. While endometrial cancer staging is done surgically according to the recent International Federation of Gynecology and Obstetrics (FIGO) 2009 classification, clinical staging is used in medically inoperable patients (Table 3) [50].
IA-Uterine cavity sounds to <8 cm |
---|
IB-Uterine cavity sounds to >8 cm |
Stage II-Involves the corpus and cervix |
Stage III-Parametrium, adnexa, or vagina but confined to true pelvis |
Stage IVA-Involving local structures (rectum/bladder) |
Stage IVB-Metastatic |
Clinical staging system for endometrial cancer.
The patients should be meticulously evaluated for pelvic examination and distant metastasis if clinical staging would be used. Vagina, cervix and the uterus are evaluated, presence of a mass lesion is examined and the search for parametrium involvement is attempted through bimanual (rectal-vaginal) examination. Computed tomographies of the thorax, abdomen and the pelvis are performed for distant metastasis and MRI is used for assessment of the uterus and the pelvis as the negative predictive value is >85% for myometrial invasion in contrast-enhanced T2-weighted MRI and the positive predictive value is low [51]. 18-F-fluoro-deoxyglucose positron emission tomography (PET) is used for lymph node involvement [52, 53]. In a study conducted with PET-CT, the pelvic node involvement rate was 63% and the para-aortic lymph node involvement was 95% [54].
The target volume has been defined as the whole uterus, cervix and the upper 3–5 cm of the vagina for inoperable endometrial cancer in the 2000 ABS guideline and mainly MRI, and if MRI is not available, CT was recommended for the treatment plan [55]. The risks for the neighboring organs should be considered when performing volume-based treatment through MRI or CT [56] (Table 4).
Structure | Image data set | Definition |
---|---|---|
Gross tumor volume clinical target volume Organs at risk | T2-wcightcd MRI MRI or CT MRI or CT | Visible abnormality if present Entire uterus, cervix, and upper 1–2 cm of the vagina Sigmoid, rectum, bladder, bowel, and uninvolved lower third of the vagina |
Recommended structures for volume-based planning in medically inoperable endometrial cancer.
CT, computed tomography; MRI, magnetic resonance imaging.
Note. MRI is required if a gross tumor volume is to be contoured. The clinical target volume includes the entire uterus, cervix, and upper vagina. Organs at risk include bladder, rectum, and sigmoid.
In a study of Gill et al., 38 inoperable endometrial cancer patients underwent volume-based treatment and the gross tumor volume (GTV) and the clinical target volume (CTV) were determined with MRI in 19 patients and with CT in the remaining 19. While 20 patients received a mean 37.5 Gy VB in 4–5 fractions, 20 patients received 45 Gy EBRT followed by 25 Gy boost VB treatment. While the local control rate was 90.6% for 2 years, the overall survival rate was 94.4%. Hemorrhage developed in only one patient during the applicator placement and she received blood transfusion. No patients had grade 3 or acute and late complications [57]. The patients should be referred to centers where MRI or CT is available or their treatment should be attempted by using ultrasonography and radiography.
HDR VB may be used alone in patients who have clinical stage 1, grade 1–2 myometrial invasion of less than 50 [56]%. GTV is specified in the course of brachytherapy with MRI and the whole uterus and its serosa are irradiated (CTV). For minimal harm to the neighboring tissues (OAT), the limit is 70–75 Gy for the rectum and the sigmoid, and 80–100 Gy for the urinary bladder. The HDR dose schemas for these patients have been presented in Table 5.
Pelvic EBRT+HDR VB is recommended for clinical stage 1 patients with myometrial invasion >50%. EBRT is applied 45–50 Gy so as to include all pelvic lymph nodes, the whole uterus and 1–2 cm proximal of vagina. Dose schemas are presented in Table 6 for these patients.
Patients with clinical stage 2 endometrial cancer are given pelvic EBRT + HDR VB. This treatment modality is also valid for clinics that do not have MRI. The doses presented in Table 6 are used.
Higher doses of pelvic EBRT (including all lymphatic regions) up to 65 Gy + HDR VB are given to patients with clinical stage 3 endometrial cancer. The doses presented in Table 6 are used.
HDR total dose (Gy) | HDR dose fractionation | EQD2 (Gy) |
---|---|---|
36 | 6 Gy × 6 | 48 |
38.4 | 6.4 Gy × 6 | 52.5 |
363 | 7.3 Gy × 5 | 52.6 |
34 | 8.5 Gy × 4 | 52.4 |
40–50 | 5 Gy × 9–10 | 50–62.5 |
HDR dose table.
EBRT (Gy) | HDR total dose (Gy) | HDR dose fractionation | EQD2 (Gy) |
---|---|---|---|
45 | 19.5 | 6.5 Gy × 3 | 71.1 |
45 | 18.9 | 6.3 Gy × 3 | 69.9 |
45 | 20.8 | 5.2 Gy × 4 | 70.6 |
45 | 25 | 5 Gy × 5 | 75 |
45 | 17 | 8.5 Gy × 2 | 70.5 |
50.4 | 12 | 6.0 Gy × 2 | 65.6 |
50.4 | 22.5 | 3.75 Gy × 6 | 75.3 |
EBRT and HDR dose schemas.
Radiotherapy options are quite limited in biopsy-proven recurrences after definitive radiation treatment. It may only be used for palliative purposes in vaginal hemorrhage and pelvic pain. Hormone therapy and chemotherapy options should be considered in patients with recurrence [58].
In the literature, radiotherapy was shown to have been used in 60% of cervical cancers, 45% of endometrial cancers and 100% of vaginal cancers [59, 60]. Healthy cervical and uterine tissues are known to tolerate radiation therapy (RT) well. Although pregnancy is known to have occurred in women receiving 20–30 Gy RT for the uterus, an atrophic uterus improper for pregnancy develops in women receiving 40–50 Gy. The toxic effect of RT depends on the age for ovaries; exposure to 20 Gy usually results in ovarian insufficiency in an adult woman. The influence of RT on the vagina depends on the location (superior, medial, inferior, posterior or the anterior wall). While the proximal vagina seems to be resistant to high doses (>100 Gy), the distal and the posterior walls are susceptible to atrophy and stenosis. While the rectum and the urinary bladder can be treated with low risk with 45–50 Gy RT, the small intestine shows severe toxic effects against <30 Gy, depending on the treated volume. These toxic effects of RT are known to be related to the treated tissue amount, fraction number and dose, previous surgeries, concurrent chemotherapies, co-morbid conditions and the smoking status [61].
Acute toxicity is defined as conditions that develop in the course of RT.
Sub-acute toxicity is defined as conditions that develop between 4 and 12 weeks after termination of RT.
Late toxicity is defined as the irreversible reactions that develop 3 months after termination of the treatment.
The patient is asked to come to the treatment with a full urinary bladder with the aim of moving away the bowels as the urinary bladder can tolerate RT relatively better than the bowels.
This is among the most common RT-induced complications. The patients present with urinary symptoms (dysuria, frequency, urgency and nocturia). Infectious cystitis should be excluded. The symptoms usually recover spontaneously within 1–2 weeks. Genitor-urinary complaints were reported to be seen less frequently when adjuvant therapy was performed with intensity-modulated radiation therapy (IMRT) [62].
This toxic effect of RT emerges as the urinary bladder epithelium and the micro-vascular circulation are affected. Fibrosis and collagen accumulate under the epithelium and the muscle layer, and the urinary bladder capacity decreases. This effect leads to over-activity and contraction of the urinary bladder resulting in urge incontinence. In the PORTEC-1 study, while grade 3–4 toxicity was not observed, the rate of grade 1–2 genito-urinary complication was 5% higher [11].
Hematuria and ulcer formation are the late GU findings. Recurrent urinary bladder stones may be formed. Ureto-vaginal or vesico-vaginal fistulae may also develop following brachytherapy [63].
Gastro-intestinal toxicity may develop during RT or later and impair the quality of life of the patients through leading to restrictions in the daily lives of the patients.
As the small intestine epithelium shows a rapid proliferation, it is affected to a higher extent by RT. While nausea and vomiting are seen at the beginning of the treatment, abdominal cramps and diarrhea are experienced during the following 2–3 weeks. This effect is considered to result from the disappearance of small intestine crypts and the inability to restore them in a short while [64]. The acute effects in the colon include fecal urgency and tenesmus. Acute colonic problems are seen in approximately 50% of the patients who receive 45–50 Gy as adjuvant; however, acute grade 3 toxicity is lower than 3% [10, 30]. There are randomized studies reporting that these acute effects may be significantly reduced by using IMRT [65].
Late effects may develop between 6 months and several years in most patients. The pathophysiology includes chronic enteropathy with mucosal atrophy and loss of mucin-producing goblet cells. Fibrosis in the intestinal walls causes dysmotility and acute obstruction. There are no techniques that do not cause late intestinal complications, including IMRT. The late toxic intestinal effects include chronic diarrhea, malabsorption, recurrent ileus, mucosal ulcer, telangiectasias and rectal proctopathy.
Vaginal complications are commonly seen both during pelvic EBRT and VB. This toxic effect impairs the quality of life of the patients by leading to sexual dysfunction. Vaginal toxicity above grade 2 was not reported when the vaginal cuff was treated with HDR VB alone in a study [23].
Erythema and superficial ulcers develop as a result of vaginal surface epithelium injury in patients receiving brachytherapy. This leads to exudative vaginal discharge and may result in secondary infections.
This complication is particularly seen when interstitial brachytherapy is used for treatment of full-thickness vaginal mucosa involvement [66].
This is a common late complication of both pelvic EBRT and VB. Dyspareunia is common due to reduced vaginal length. Vaginal stenosis and complete closure should be prevented to achieve a satisfactory follow-up. Stenosis usually develops 3–6 months after therapy. Vaginal dilators with proper thickness and length are used for the primary repair in these patients. While some authors propose that the use of vaginal dilators after RT reduces the stenosis, some others propose that it is not much effective [67].
As this section deals with legal issues pertaining to the rights of individual Authors and IntechOpen, for the avoidance of doubt, each category of publication is dealt with separately. Consequently, much of the information, for example definition of terms used, is repeated to ensure that there can be no misunderstanding of the policies that apply to each category.
",metaTitle:"Copyright Policy",metaDescription:"Copyright is the term used to describe the rights related to the publication and distribution of original works. Most importantly from a publisher's perspective, copyright governs how authors, publishers and the general public can use, publish and distribute publications.",metaKeywords:null,canonicalURL:"/page/copyright-policy",contentRaw:'[{"type":"htmlEditorComponent","content":"Copyright is the term used to describe the rights related to the publication and distribution of original Works. Most importantly from a publisher's perspective, copyright governs how Authors, publishers and the general public can use, publish, and distribute publications.
\\n\\nIntechOpen only publishes manuscripts for which it has publishing rights. This is governed by a publication agreement between the Author and IntechOpen. This agreement is accepted by the Author when the manuscript is submitted and deals with both the rights of the publisher and Author, as well as any obligations concerning a particular manuscript. However, in accepting this agreement, Authors continue to retain significant rights to use and share their publications.
\\n\\nHOW COPYRIGHT WORKS WITH OPEN ACCESS LICENSES?
\\n\\nAgreement samples are listed here for the convenience of prospective Authors:
\\n\\n\\n\\nDEFINITIONS
\\n\\nThe following definitions apply in this Copyright Policy:
\\n\\nAuthor - in order to be identified as an Author, three criteria must be met: (i) Substantial contribution to the conception or design of the Work, or the acquisition, analysis, or interpretation of data for the Work; (ii) Participation in drafting or revising the Work; (iii) Approval of the final version of the Work to be published.
\\n\\nWork - a Chapter, including Conference Papers, and any and all text, graphics, images and/or other materials forming part of or accompanying the Chapter/Conference Paper.
\\n\\nMonograph/Compacts - a full manuscript usually written by a single Author, including any and all text, graphics, images and/or other materials.
\\n\\nCompilation - a collection of Works distributed in a Book that IntechOpen has selected, and for which the coordination of the preparation, arrangement and publication has been the responsibility of IntechOpen. Any Work included is accepted in its entirety in unmodified form and is published with one or more other contributions, each constituting a separate and independent Work, but which together are assembled into a collective whole.
\\n\\nIntechOpen - Registered publisher with office at 5 Princes Gate Court, London, SW7 2QJ - UNITED KINGDOM
\\n\\nIntechOpen platform - IntechOpen website www.intechopen.com whose main purpose is to host Monographs in the format of Book Chapters, Long Form Monographs, Compacts, Conference Proceedings and Videos.
\\n\\nVideo Lecture – an audiovisual recording of a lecture or a speech given by a Lecturer, recorded, edited, owned and published by IntechOpen.
\\n\\nTERMS
\\n\\nAll Works published on the IntechOpen platform and in print are licensed under a Creative Commons Attribution 3.0 Unported License, a license which allows for the broadest possible reuse of published material.
\\n\\nCopyright on the individual Works belongs to the specific Author, subject to an agreement with IntechOpen. The Creative Common license is granted to all others to:
\\n\\nAnd for any purpose, provided the following conditions are met:
\\n\\nAll Works are published under the CC BY 3.0 license. However, please note that book Chapters may fall under a different CC license, depending on their publication date as indicated in the table below:
\\n\\n\\n\\n
LICENSE | \\n\\t\\t\\tUSED FROM - | \\n\\t\\t\\tUP TO - | \\n\\t\\t
\\n\\t\\t\\t Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0) \\n\\t\\t\\t | \\n\\t\\t\\t\\n\\t\\t\\t 1 July 2005 (2005-07-01) \\n\\t\\t\\t | \\n\\t\\t\\t\\n\\t\\t\\t 3 October 2011 (2011-10-03) \\n\\t\\t\\t | \\n\\t\\t
Creative Commons Attribution 3.0 Unported (CC BY 3.0) | \\n\\t\\t\\t\\n\\t\\t\\t 5 October 2011 (2011-10-05) \\n\\t\\t\\t | \\n\\t\\t\\tCurrently | \\n\\t\\t
The CC BY 3.0 license permits Works to be freely shared in any medium or format, as well as the reuse and adaptation of the original contents of Works (e.g. figures and tables created by the Authors), as long as the source Work is cited and its Authors are acknowledged in the following manner:
\\n\\nContent reuse:
\\n\\n© {year} {authors' full names}. Originally published in {short citation} under {license version} license. Available from: {DOI}
\\n\\nContent adaptation & reuse:
\\n\\n© {year} {authors' full names}. Adapted from {short citation}; originally published under {license version} license. Available from: {DOI}
\\n\\nReposting & sharing:
\\n\\nOriginally published in {full citation}. Available from: {DOI}
\\n\\nRepublishing – More about Attribution Policy can be found here.
\\n\\nThe same principles apply to Works published under the CC BY-NC-SA 3.0 license, with the caveats that (1) the content may not be used for commercial purposes, and (2) derivative works building on this content must be distributed under the same license. The restrictions contained in these license terms may, however, be waived by the copyright holder(s). Users wishing to circumvent any of the license terms are required to obtain explicit permission to do so from the copyright holder(s).
\\n\\nDISCLAIMER: Neither the CC BY 3.0 license, nor any other license IntechOpen currently uses or has used before, applies to figures and tables reproduced from other works, as they may be subject to different terms of reuse. In such cases, if the copyright holder is not noted in the source of a figure or table, it is the responsibility of the User to investigate and determine the exact copyright status of any information utilised. Users requiring assistance in that regard are welcome to send an inquiry to permissions@intechopen.com.
\\n\\nAll rights to Books and all other compilations published on the IntechOpen platform and in print are reserved by IntechOpen.
\\n\\nThe copyright to Books and other compilations is subject to separate copyright from those that exist in the included Works.
\\n\\nAll Long Form Monographs/Compacts are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license granted to all others.
\\n\\nCopyright to the individual Works (Chapters) belongs to their specific Authors, subject to an agreement with IntechOpen and the Creative Common license granted to all others to:
\\n\\nUnder the following terms:
\\n\\nThere must be an Attribution, giving appropriate credit, provision of a link to the license, and indication if any changes were made.
\\n\\nNonCommercial - The use of the material for commercial purposes is prohibited. Commercial rights are reserved to IntechOpen or its licensees.
\\n\\nNo additional restrictions that apply legal terms or technological measures that restrict others from doing anything the license permits are allowed.
\\n\\nThe CC BY-NC 4.0 license permits Works to be freely shared in any medium or format, as well as reuse and adaptation of the original contents of Works (e.g. figures and tables created by the Authors), as long as it is not used for commercial purposes. The source Work must be cited and its Authors acknowledged in the following manner:
\\n\\nContent reuse:
\\n\\n© {year} {authors' full names}. Originally published in {short citation} under {license version} license. Available from: {DOI}
\\n\\nContent adaptation & reuse:
\\n\\n© {year} {authors' full names}. Adapted from {short citation}; originally published under {license version} license. Available from: {DOI}
\\n\\nReposting & sharing:
\\n\\nOriginally published in {full citation}. Available from: {DOI}
\\n\\nAll Book cover design elements, as well as Video image graphics are subject to copyright by IntechOpen.
\\n\\nEvery reproduction of a front cover image must be accompanied by an appropriate Copyright Notice displayed adjacent to the image. The exact Copyright Notice depends on who the Author of a particular cover image is. Users wishing to reproduce cover images should contact permissions@intechopen.com.
\\n\\nAll Video Lectures under IntechOpen's production are subject to copyright and are property of IntechOpen, unless defined otherwise, and are licensed under the Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This grants all others the right to:
\\n\\nShare — copy and redistribute the material in any medium or format
\\n\\nUnder the following terms:
\\n\\nUsers wishing to repost and share the Video Lectures are welcome to do so as long as they acknowledge the source in the following manner:
\\n\\n© {year} IntechOpen. Published under CC BY-NC-ND 4.0 license. Available from: {DOI}
\\n\\nUsers wishing to reuse, modify, or adapt the Video Lectures in a way not permitted by the license are welcome to contact us at permissions@intechopen.com to discuss waiving particular license terms.
\\n\\nAll software used on the IntechOpen platform, any used during the publishing process, and the copyright in the code constituting such software, is the property of IntechOpen or its software suppliers. As such, it may not be downloaded or copied without permission.
\\n\\nUnless otherwise indicated, all IntechOpen websites are the property of IntechOpen.
\\n\\nAll content included on IntechOpen Websites not forming part of contributed materials (such as text, images, logos, graphics, design elements, videos, sounds, pictures, trademarks, etc.), are subject to copyright and are property of, or licensed to, IntechOpen. Any other use, including the reproduction, modification, distribution, transmission, republication, display, or performance of the content on this site is strictly prohibited.
\\n\\nPolicy last updated: 2016-06-08
\\n"}]'},components:[{type:"htmlEditorComponent",content:'Copyright is the term used to describe the rights related to the publication and distribution of original Works. Most importantly from a publisher's perspective, copyright governs how Authors, publishers and the general public can use, publish, and distribute publications.
\n\nIntechOpen only publishes manuscripts for which it has publishing rights. This is governed by a publication agreement between the Author and IntechOpen. This agreement is accepted by the Author when the manuscript is submitted and deals with both the rights of the publisher and Author, as well as any obligations concerning a particular manuscript. However, in accepting this agreement, Authors continue to retain significant rights to use and share their publications.
\n\nHOW COPYRIGHT WORKS WITH OPEN ACCESS LICENSES?
\n\nAgreement samples are listed here for the convenience of prospective Authors:
\n\n\n\nDEFINITIONS
\n\nThe following definitions apply in this Copyright Policy:
\n\nAuthor - in order to be identified as an Author, three criteria must be met: (i) Substantial contribution to the conception or design of the Work, or the acquisition, analysis, or interpretation of data for the Work; (ii) Participation in drafting or revising the Work; (iii) Approval of the final version of the Work to be published.
\n\nWork - a Chapter, including Conference Papers, and any and all text, graphics, images and/or other materials forming part of or accompanying the Chapter/Conference Paper.
\n\nMonograph/Compacts - a full manuscript usually written by a single Author, including any and all text, graphics, images and/or other materials.
\n\nCompilation - a collection of Works distributed in a Book that IntechOpen has selected, and for which the coordination of the preparation, arrangement and publication has been the responsibility of IntechOpen. Any Work included is accepted in its entirety in unmodified form and is published with one or more other contributions, each constituting a separate and independent Work, but which together are assembled into a collective whole.
\n\nIntechOpen - Registered publisher with office at 5 Princes Gate Court, London, SW7 2QJ - UNITED KINGDOM
\n\nIntechOpen platform - IntechOpen website www.intechopen.com whose main purpose is to host Monographs in the format of Book Chapters, Long Form Monographs, Compacts, Conference Proceedings and Videos.
\n\nVideo Lecture – an audiovisual recording of a lecture or a speech given by a Lecturer, recorded, edited, owned and published by IntechOpen.
\n\nTERMS
\n\nAll Works published on the IntechOpen platform and in print are licensed under a Creative Commons Attribution 3.0 Unported License, a license which allows for the broadest possible reuse of published material.
\n\nCopyright on the individual Works belongs to the specific Author, subject to an agreement with IntechOpen. The Creative Common license is granted to all others to:
\n\nAnd for any purpose, provided the following conditions are met:
\n\nAll Works are published under the CC BY 3.0 license. However, please note that book Chapters may fall under a different CC license, depending on their publication date as indicated in the table below:
\n\n\n\n
LICENSE | \n\t\t\tUSED FROM - | \n\t\t\tUP TO - | \n\t\t
\n\t\t\t Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0) \n\t\t\t | \n\t\t\t\n\t\t\t 1 July 2005 (2005-07-01) \n\t\t\t | \n\t\t\t\n\t\t\t 3 October 2011 (2011-10-03) \n\t\t\t | \n\t\t
Creative Commons Attribution 3.0 Unported (CC BY 3.0) | \n\t\t\t\n\t\t\t 5 October 2011 (2011-10-05) \n\t\t\t | \n\t\t\tCurrently | \n\t\t
The CC BY 3.0 license permits Works to be freely shared in any medium or format, as well as the reuse and adaptation of the original contents of Works (e.g. figures and tables created by the Authors), as long as the source Work is cited and its Authors are acknowledged in the following manner:
\n\nContent reuse:
\n\n© {year} {authors' full names}. Originally published in {short citation} under {license version} license. Available from: {DOI}
\n\nContent adaptation & reuse:
\n\n© {year} {authors' full names}. Adapted from {short citation}; originally published under {license version} license. Available from: {DOI}
\n\nReposting & sharing:
\n\nOriginally published in {full citation}. Available from: {DOI}
\n\nRepublishing – More about Attribution Policy can be found here.
\n\nThe same principles apply to Works published under the CC BY-NC-SA 3.0 license, with the caveats that (1) the content may not be used for commercial purposes, and (2) derivative works building on this content must be distributed under the same license. The restrictions contained in these license terms may, however, be waived by the copyright holder(s). Users wishing to circumvent any of the license terms are required to obtain explicit permission to do so from the copyright holder(s).
\n\nDISCLAIMER: Neither the CC BY 3.0 license, nor any other license IntechOpen currently uses or has used before, applies to figures and tables reproduced from other works, as they may be subject to different terms of reuse. In such cases, if the copyright holder is not noted in the source of a figure or table, it is the responsibility of the User to investigate and determine the exact copyright status of any information utilised. Users requiring assistance in that regard are welcome to send an inquiry to permissions@intechopen.com.
\n\nAll rights to Books and all other compilations published on the IntechOpen platform and in print are reserved by IntechOpen.
\n\nThe copyright to Books and other compilations is subject to separate copyright from those that exist in the included Works.
\n\nAll Long Form Monographs/Compacts are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license granted to all others.
\n\nCopyright to the individual Works (Chapters) belongs to their specific Authors, subject to an agreement with IntechOpen and the Creative Common license granted to all others to:
\n\nUnder the following terms:
\n\nThere must be an Attribution, giving appropriate credit, provision of a link to the license, and indication if any changes were made.
\n\nNonCommercial - The use of the material for commercial purposes is prohibited. Commercial rights are reserved to IntechOpen or its licensees.
\n\nNo additional restrictions that apply legal terms or technological measures that restrict others from doing anything the license permits are allowed.
\n\nThe CC BY-NC 4.0 license permits Works to be freely shared in any medium or format, as well as reuse and adaptation of the original contents of Works (e.g. figures and tables created by the Authors), as long as it is not used for commercial purposes. The source Work must be cited and its Authors acknowledged in the following manner:
\n\nContent reuse:
\n\n© {year} {authors' full names}. Originally published in {short citation} under {license version} license. Available from: {DOI}
\n\nContent adaptation & reuse:
\n\n© {year} {authors' full names}. Adapted from {short citation}; originally published under {license version} license. Available from: {DOI}
\n\nReposting & sharing:
\n\nOriginally published in {full citation}. Available from: {DOI}
\n\nAll Book cover design elements, as well as Video image graphics are subject to copyright by IntechOpen.
\n\nEvery reproduction of a front cover image must be accompanied by an appropriate Copyright Notice displayed adjacent to the image. The exact Copyright Notice depends on who the Author of a particular cover image is. Users wishing to reproduce cover images should contact permissions@intechopen.com.
\n\nAll Video Lectures under IntechOpen's production are subject to copyright and are property of IntechOpen, unless defined otherwise, and are licensed under the Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This grants all others the right to:
\n\nShare — copy and redistribute the material in any medium or format
\n\nUnder the following terms:
\n\nUsers wishing to repost and share the Video Lectures are welcome to do so as long as they acknowledge the source in the following manner:
\n\n© {year} IntechOpen. Published under CC BY-NC-ND 4.0 license. Available from: {DOI}
\n\nUsers wishing to reuse, modify, or adapt the Video Lectures in a way not permitted by the license are welcome to contact us at permissions@intechopen.com to discuss waiving particular license terms.
\n\nAll software used on the IntechOpen platform, any used during the publishing process, and the copyright in the code constituting such software, is the property of IntechOpen or its software suppliers. As such, it may not be downloaded or copied without permission.
\n\nUnless otherwise indicated, all IntechOpen websites are the property of IntechOpen.
\n\nAll content included on IntechOpen Websites not forming part of contributed materials (such as text, images, logos, graphics, design elements, videos, sounds, pictures, trademarks, etc.), are subject to copyright and are property of, or licensed to, IntechOpen. Any other use, including the reproduction, modification, distribution, transmission, republication, display, or performance of the content on this site is strictly prohibited.
\n\nPolicy last updated: 2016-06-08
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5774},{group:"region",caption:"Middle and South America",value:2,count:5239},{group:"region",caption:"Africa",value:3,count:1721},{group:"region",caption:"Asia",value:4,count:10411},{group:"region",caption:"Australia and Oceania",value:5,count:897},{group:"region",caption:"Europe",value:6,count:15810}],offset:12,limit:12,total:118377},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"dateEndThirdStepPublish"},books:[{type:"book",id:"10231",title:"Proton Therapy",subtitle:null,isOpenForSubmission:!0,hash:"f4a9009287953c8d1d89f0fa9b7597b0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10231.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10652",title:"Visual Object Tracking",subtitle:null,isOpenForSubmission:!0,hash:"96f3ee634a7ba49fa195e50475412af4",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10652.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10653",title:"Optimization Algorithms",subtitle:null,isOpenForSubmission:!0,hash:"753812dbb9a6f6b57645431063114f6c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10653.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10655",title:"Motion Planning",subtitle:null,isOpenForSubmission:!0,hash:"809b5e290cf2dade9e7e0a5ae0ef3df0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10655.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10657",title:"Service Robots",subtitle:null,isOpenForSubmission:!0,hash:"5f81b9eea6eb3f9af984031b7af35588",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10657.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10662",title:"Pedagogy",subtitle:null,isOpenForSubmission:!0,hash:"c858e1c6fb878d3b895acbacec624576",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10662.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10673",title:"The Psychology of Trust",subtitle:null,isOpenForSubmission:!0,hash:"1f6cac41fd145f718ac0866264499cc8",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10673.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10675",title:"Hydrostatics",subtitle:null,isOpenForSubmission:!0,hash:"c86c2fa9f835d4ad5e7efd8b01921866",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10675.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10677",title:"Topology",subtitle:null,isOpenForSubmission:!0,hash:"85eac84b173d785f989522397616124e",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10677.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10678",title:"Biostatistics",subtitle:null,isOpenForSubmission:!0,hash:"f63db439474a574454a66894db8b394c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10678.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10679",title:"Mass Production",subtitle:null,isOpenForSubmission:!0,hash:"2dae91102099b1a07be1a36a68852829",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10679.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10689",title:"Risk Management in Construction",subtitle:null,isOpenForSubmission:!0,hash:"e3805b3d2fceb9d33e1fa805687cd296",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10689.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:18},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:5},{group:"topic",caption:"Business, Management and Economics",value:7,count:2},{group:"topic",caption:"Chemistry",value:8,count:8},{group:"topic",caption:"Computer and Information Science",value:9,count:6},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:7},{group:"topic",caption:"Engineering",value:11,count:20},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:4},{group:"topic",caption:"Materials Science",value:14,count:5},{group:"topic",caption:"Mathematics",value:15,count:1},{group:"topic",caption:"Medicine",value:16,count:25},{group:"topic",caption:"Neuroscience",value:18,count:2},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:3},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Robotics",value:22,count:1},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:1}],offset:12,limit:12,total:202},popularBooks:{featuredBooks:[{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5249},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editedByType:"Edited by",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editedByType:"Edited by",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editedByType:"Edited by",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editedByType:"Edited by",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9669",title:"Recent Advances in Rice Research",subtitle:null,isOpenForSubmission:!1,hash:"12b06cc73e89af1e104399321cc16a75",slug:"recent-advances-in-rice-research",bookSignature:"Mahmood-ur- Rahman Ansari",coverURL:"https://cdn.intechopen.com/books/images_new/9669.jpg",editedByType:"Edited by",editors:[{id:"185476",title:"Dr.",name:"Mahmood-Ur-",middleName:null,surname:"Rahman Ansari",slug:"mahmood-ur-rahman-ansari",fullName:"Mahmood-Ur- Rahman Ansari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editedByType:"Edited by",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editedByType:"Edited by",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editedByType:"Edited by",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editedByType:"Edited by",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editedByType:"Edited by",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"166",title:"Statistics",slug:"mathematics-statistics",parent:{title:"Mathematics",slug:"mathematics"},numberOfBooks:10,numberOfAuthorsAndEditors:148,numberOfWosCitations:86,numberOfCrossrefCitations:93,numberOfDimensionsCitations:161,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"mathematics-statistics",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"9218",title:"Bayesian Inference on Complicated Data",subtitle:null,isOpenForSubmission:!1,hash:"5cf83c23db5b0ae47192d34ec8091162",slug:"bayesian-inference-on-complicated-data",bookSignature:"Niansheng Tang",coverURL:"https://cdn.intechopen.com/books/images_new/9218.jpg",editedByType:"Edited by",editors:[{id:"221831",title:"Prof.",name:"Niansheng",middleName:null,surname:"Tang",slug:"niansheng-tang",fullName:"Niansheng Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7680",title:"Statistical Methodologies",subtitle:null,isOpenForSubmission:!1,hash:"b9ba6b053350f5e59925bce32b1d692d",slug:"statistical-methodologies",bookSignature:"Jan Peter Hessling",coverURL:"https://cdn.intechopen.com/books/images_new/7680.jpg",editedByType:"Edited by",editors:[{id:"20815",title:"Dr.",name:"Jan Peter",middleName:null,surname:"Hessling",slug:"jan-peter-hessling",fullName:"Jan Peter Hessling"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7372",title:"Bayesian Networks",subtitle:"Advances and Novel Applications",isOpenForSubmission:!1,hash:"ee81401d110a5f6bca2997a28e8d169b",slug:"bayesian-networks-advances-and-novel-applications",bookSignature:"Douglas McNair",coverURL:"https://cdn.intechopen.com/books/images_new/7372.jpg",editedByType:"Edited by",editors:[{id:"219757",title:"Dr.",name:"Douglas",middleName:null,surname:"McNair",slug:"douglas-mcnair",fullName:"Douglas McNair"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8362",title:"Time Series Analysis",subtitle:"Data, Methods, and Applications",isOpenForSubmission:!1,hash:"7e98dd03d921c19cc2324e91845d5160",slug:"time-series-analysis-data-methods-and-applications",bookSignature:"Chun-Kit Ngan",coverURL:"https://cdn.intechopen.com/books/images_new/8362.jpg",editedByType:"Edited by",editors:[{id:"227503",title:"Dr.",name:"Chun-Kit",middleName:null,surname:"Ngan",slug:"chun-kit-ngan",fullName:"Chun-Kit Ngan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6703",title:"Statistics",subtitle:"Growing Data Sets and Growing Demand for Statistics",isOpenForSubmission:!1,hash:"f67636870f28cdf080018abaddd953d2",slug:"statistics-growing-data-sets-and-growing-demand-for-statistics",bookSignature:"Türkmen Göksel",coverURL:"https://cdn.intechopen.com/books/images_new/6703.jpg",editedByType:"Edited by",editors:[{id:"190299",title:"Dr.",name:"Türkmen",middleName:null,surname:"Göksel",slug:"turkmen-goksel",fullName:"Türkmen Göksel"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5856",title:"Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes",subtitle:null,isOpenForSubmission:!1,hash:"950e8a681056d4b6bdc024121529d1ce",slug:"statistical-approaches-with-emphasis-on-design-of-experiments-applied-to-chemical-processes",bookSignature:"Valter Silva",coverURL:"https://cdn.intechopen.com/books/images_new/5856.jpg",editedByType:"Edited by",editors:[{id:"187136",title:"Dr.",name:"Valter",middleName:null,surname:"Silva",slug:"valter-silva",fullName:"Valter Silva"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5964",title:"Bayesian Inference",subtitle:null,isOpenForSubmission:!1,hash:"b05b9b63cb02573c7e0cc5e877e35c61",slug:"bayesian-inference",bookSignature:"Javier Prieto Tejedor",coverURL:"https://cdn.intechopen.com/books/images_new/5964.jpg",editedByType:"Edited by",editors:[{id:"177972",title:"Dr.",name:"Javier Prieto",middleName:null,surname:"Tejedor",slug:"javier-prieto-tejedor",fullName:"Javier Prieto Tejedor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5446",title:"Advances in Statistical Methodologies and Their Application to Real Problems",subtitle:null,isOpenForSubmission:!1,hash:"93e5e8e7a09c351b3e0377d6ac6ccc35",slug:"advances-in-statistical-methodologies-and-their-application-to-real-problems",bookSignature:"Tsukasa Hokimoto",coverURL:"https://cdn.intechopen.com/books/images_new/5446.jpg",editedByType:"Edited by",editors:[{id:"69561",title:"Dr.",name:"Tsukasa",middleName:null,surname:"Hokimoto",slug:"tsukasa-hokimoto",fullName:"Tsukasa Hokimoto"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3812",title:"Dynamic Programming and Bayesian Inference",subtitle:"Concepts and Applications",isOpenForSubmission:!1,hash:"f507023ddf3414519592ec0f0d6b25e3",slug:"dynamic-programming-and-bayesian-inference-concepts-and-applications",bookSignature:"Mohammad Saber Fallah Nezhad",coverURL:"https://cdn.intechopen.com/books/images_new/3812.jpg",editedByType:"Edited by",editors:[{id:"150393",title:"Dr.",name:"Mohammad Saber Fallah",middleName:null,surname:"Nezhad",slug:"mohammad-saber-fallah-nezhad",fullName:"Mohammad Saber Fallah Nezhad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2155",title:"Bayesian Networks",subtitle:null,isOpenForSubmission:!1,hash:"2c08ecbb5580e47a9c16cdaec48c2adc",slug:"bayesian-networks",bookSignature:"Wichian Premchaiswadi",coverURL:"https://cdn.intechopen.com/books/images_new/2155.jpg",editedByType:"Edited by",editors:[{id:"10820",title:"Dr.",name:"Wichian",middleName:null,surname:"Premchaiswadi",slug:"wichian-premchaiswadi",fullName:"Wichian Premchaiswadi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:10,mostCitedChapters:[{id:"59209",doi:"10.5772/intechopen.73690",title:"Utilization of Response Surface Methodology in Optimization of Extraction of Plant Materials",slug:"utilization-of-response-surface-methodology-in-optimization-of-extraction-of-plant-materials",totalDownloads:3648,totalCrossrefCites:20,totalDimensionsCites:28,book:{slug:"statistical-approaches-with-emphasis-on-design-of-experiments-applied-to-chemical-processes",title:"Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes",fullTitle:"Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes"},signatures:"Alev Yüksel Aydar",authors:[{id:"218870",title:"Dr.",name:"Alev Yüksel",middleName:null,surname:"Aydar",slug:"alev-yuksel-aydar",fullName:"Alev Yüksel Aydar"}]},{id:"56460",doi:"10.5772/intechopen.69501",title:"Application of Taguchi-Based Design of Experiments for Industrial Chemical Processes",slug:"application-of-taguchi-based-design-of-experiments-for-industrial-chemical-processes",totalDownloads:2134,totalCrossrefCites:9,totalDimensionsCites:21,book:{slug:"statistical-approaches-with-emphasis-on-design-of-experiments-applied-to-chemical-processes",title:"Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes",fullTitle:"Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes"},signatures:"Rahul Davis and Pretesh John",authors:[{id:"199438",title:"Mr.",name:"Rahul",middleName:null,surname:"Davis",slug:"rahul-davis",fullName:"Rahul Davis"}]},{id:"64216",doi:"10.5772/intechopen.81170",title:"CNN Approaches for Time Series Classification",slug:"cnn-approaches-for-time-series-classification",totalDownloads:2607,totalCrossrefCites:8,totalDimensionsCites:12,book:{slug:"time-series-analysis-data-methods-and-applications",title:"Time Series Analysis",fullTitle:"Time Series Analysis - Data, Methods, and Applications"},signatures:"Lamyaa Sadouk",authors:[{id:"257943",title:"Ph.D.",name:"Lamyaa",middleName:null,surname:"Sadouk",slug:"lamyaa-sadouk",fullName:"Lamyaa Sadouk"}]}],mostDownloadedChaptersLast30Days:[{id:"59209",title:"Utilization of Response Surface Methodology in Optimization of Extraction of Plant Materials",slug:"utilization-of-response-surface-methodology-in-optimization-of-extraction-of-plant-materials",totalDownloads:3659,totalCrossrefCites:20,totalDimensionsCites:28,book:{slug:"statistical-approaches-with-emphasis-on-design-of-experiments-applied-to-chemical-processes",title:"Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes",fullTitle:"Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes"},signatures:"Alev Yüksel Aydar",authors:[{id:"218870",title:"Dr.",name:"Alev Yüksel",middleName:null,surname:"Aydar",slug:"alev-yuksel-aydar",fullName:"Alev Yüksel Aydar"}]},{id:"56460",title:"Application of Taguchi-Based Design of Experiments for Industrial Chemical Processes",slug:"application-of-taguchi-based-design-of-experiments-for-industrial-chemical-processes",totalDownloads:2142,totalCrossrefCites:9,totalDimensionsCites:21,book:{slug:"statistical-approaches-with-emphasis-on-design-of-experiments-applied-to-chemical-processes",title:"Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes",fullTitle:"Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes"},signatures:"Rahul Davis and Pretesh John",authors:[{id:"199438",title:"Mr.",name:"Rahul",middleName:null,surname:"Davis",slug:"rahul-davis",fullName:"Rahul Davis"}]},{id:"56653",title:"Bayesian Hypothesis Testing: An Alternative to Null Hypothesis Significance Testing (NHST) in Psychology and Social Sciences",slug:"bayesian-hypothesis-testing-an-alternative-to-null-hypothesis-significance-testing-nhst-in-psycholog",totalDownloads:2607,totalCrossrefCites:7,totalDimensionsCites:8,book:{slug:"bayesian-inference",title:"Bayesian Inference",fullTitle:"Bayesian Inference"},signatures:"Alonso Ortega and Gorka Navarrete",authors:[{id:"203438",title:"Dr.",name:"Alonso",middleName:null,surname:"Ortega",slug:"alonso-ortega",fullName:"Alonso Ortega"},{id:"208842",title:"Dr.",name:"Gorka",middleName:null,surname:"Navarrete",slug:"gorka-navarrete",fullName:"Gorka Navarrete"}]},{id:"61268",title:"The Application of Discrete Choice Models in Transport",slug:"the-application-of-discrete-choice-models-in-transport",totalDownloads:995,totalCrossrefCites:1,totalDimensionsCites:0,book:{slug:"statistics-growing-data-sets-and-growing-demand-for-statistics",title:"Statistics",fullTitle:"Statistics - Growing Data Sets and Growing Demand for Statistics"},signatures:"Foued Aloulou",authors:null},{id:"71603",title:"A Brief Tour of Bayesian Sampling Methods",slug:"a-brief-tour-of-bayesian-sampling-methods",totalDownloads:376,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"bayesian-inference-on-complicated-data",title:"Bayesian Inference on Complicated Data",fullTitle:"Bayesian Inference on Complicated Data"},signatures:"Michelle Y. Wang and Trevor Park",authors:null},{id:"56066",title:"Development of Falling Film Heat Transfer Coefficient for Industrial Chemical Processes Evaporator Design",slug:"development-of-falling-film-heat-transfer-coefficient-for-industrial-chemical-processes-evaporator-d",totalDownloads:1400,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"statistical-approaches-with-emphasis-on-design-of-experiments-applied-to-chemical-processes",title:"Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes",fullTitle:"Statistical Approaches With Emphasis on Design of Experiments Applied to Chemical Processes"},signatures:"Muhammad Wakil Shahzad, Muhammad Burhan and Kim Choon\nNg",authors:[{id:"174208",title:"Dr.",name:"Muhammad Wakil",middleName:null,surname:"Shahzad",slug:"muhammad-wakil-shahzad",fullName:"Muhammad Wakil Shahzad"}]},{id:"35660",title:"Making a Predictive Diagnostic Model for Rangeland Management by Implementing a State and Transition Model Within a Bayesian Belief Network (Case Study: Ghom- Iran)",slug:"making-a-predictive-diagnostic-model-for-rangeland-management-by-implementing-a-state-and-transition",totalDownloads:1992,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"bayesian-networks",title:"Bayesian Networks",fullTitle:"Bayesian Networks"},signatures:"Hossein Bashari",authors:[{id:"10124",title:"Dr.",name:"Hossein",middleName:null,surname:"Bashari",slug:"hossein-bashari",fullName:"Hossein Bashari"}]},{id:"64216",title:"CNN Approaches for Time Series Classification",slug:"cnn-approaches-for-time-series-classification",totalDownloads:2611,totalCrossrefCites:8,totalDimensionsCites:12,book:{slug:"time-series-analysis-data-methods-and-applications",title:"Time Series Analysis",fullTitle:"Time Series Analysis - Data, Methods, and Applications"},signatures:"Lamyaa Sadouk",authors:[{id:"257943",title:"Ph.D.",name:"Lamyaa",middleName:null,surname:"Sadouk",slug:"lamyaa-sadouk",fullName:"Lamyaa Sadouk"}]},{id:"54071",title:"Validation of Instrument Measuring Continuous Variable in Medicine",slug:"validation-of-instrument-measuring-continuous-variable-in-medicine",totalDownloads:1402,totalCrossrefCites:1,totalDimensionsCites:2,book:{slug:"advances-in-statistical-methodologies-and-their-application-to-real-problems",title:"Advances in Statistical Methodologies and Their Application to Real Problems",fullTitle:"Advances in Statistical Methodologies and Their Application to Real Problems"},signatures:"Rafdzah Zaki",authors:[{id:"190238",title:"Dr.",name:"Rafdzah",middleName:null,surname:"Zaki",slug:"rafdzah-zaki",fullName:"Rafdzah Zaki"}]},{id:"68138",title:"Bayesian Graphical Model Application for Monetary Policy and Macroeconomic Performance in Nigeria",slug:"bayesian-graphical-model-application-for-monetary-policy-and-macroeconomic-performance-in-nigeria",totalDownloads:490,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"bayesian-networks-advances-and-novel-applications",title:"Bayesian Networks",fullTitle:"Bayesian Networks - Advances and Novel Applications"},signatures:"David Oluseun Olayungbo",authors:null}],onlineFirstChaptersFilter:{topicSlug:"mathematics-statistics",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"profile.detail",path:"/profiles/142774/eleftherios-bonos",hash:"",query:{},params:{id:"142774",slug:"eleftherios-bonos"},fullPath:"/profiles/142774/eleftherios-bonos",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()